ѕримечани€ книги: јнтирак груди - читать онлайн, бесплатно. јвтор: ƒжейн ѕлант

читать книги онлайн бесплатно
 
 

ќнлайн книга - јнтирак груди

–ак груди - непон€тна€ и пугающа€ тема. —уровые факты шокируют: основна€ причина смерти женщин от 25 до 75 лет - различные формы рака, и рак молочной железы - один из самых смертоносных. Ёто современное бедствие уже приобрело характер эпидемии. Ќо книга "јнтирак груди" написана не дл€ того, чтобы вы бо€лись. Ќапротив, это истори€ о надежде. ѕройд€ путь от постановки страшного диагноза к полному выздоровлению, профессор ѕлант на собственном опыте познала все этапы онкологического лечени€, изучила глубинные причины возникновени€ рака груди и составила программу преодолени€ и профилактики этого страшного заболевани€. Ѕлагодар€ дес€ти факторам питани€ и дес€ти факторам образа жизни от ƒжейн ѕлант ваша жизнь действительно будет в ваших руках.

ѕерейти к чтению книги „итать книгу Ђ јнтирак груди ї

ѕримечани€

1

Plant, Jane and Tidey, Gill, 2002. The Plant Programme. Paperback edition. Virgin Books; Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.

2

Kradjian, Robert D., 1994. Save Yourself from Breast Cancer. Berkley Publishing.

3

Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. Virgin Books.

4

ѕод хемопревентивным действием понимают способность вещества предупредить развитие рака либо затормозить его. Ц ѕримеч. ред.

5

Selected causes of death: by gender and age. Office for National Statistics; General Register Office for Scotland; Northern Ireland Statistics and Research Agency. 1997.

6

Deaths: selected causes (International Classification) and sex, 1971 onwards (England and Wales): Health Statistics Quarterly, 04. 1998

7

http://who-pcc.iarc.fr/

8

Trichopoulos, Dimitrios, Li, Frederick, P., and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80Ц85.

9

Plant, Jane A. and Moore, P. J., 1979. Geochemical mapping and interpretation in Britain. Phil. Trans. Roy. Soc., London, B288, pp. 95-112.

10

Plant, Jane A., Smith, D., Smith, B. and Williams, L., 2000. Environmental Geochemistry at the Global Scale. Geological Society Special Issue.

11

Dewey, John F., 1999. Geoscientist 9, 6 June, Society Awards, pp. 2Ц4.

12

Blair's war on cancer is a sham, say top doctors. Independent On Sunday. 14 November 1999.

13

Rennie, J, and Rusting, R., 1996. Making Headway Against Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 56-9.

14

Peto, R. and others, 2000. Smoking, Smoking Cessation and Lung Cancer in the UK since 1950. British Medical Journal, 321, 323-9.

15

Raleigh, V. S., 1999. World Population and Health in Transition. British Medical Journal, 319, 981Ц984.

16

Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy Ц a Faustian contract. Industry and Higher Education, April, 85Ц90.

17

World Health Organization's International Agency for Research on Cancer website: http://who-pcc.iarc.fr/

18

Physicians Committee for Responsible Medicine: PCRM Update of Winter 1991.

19

Cancer Research Campaign Factsheet 6.2, 1996.

20

”инстон „ерчилль был подвержен частым приступам депрессии Ц пожалуй, самого главного его врага. Ѕезысходна€ тоска охватывала „ерчилл€ в периоды мучительных, неотв€зных кризисов, и тогда ему казалось, что Ђогромный черный песї, как он говорил, преследует его по п€там. Ц ѕримеч. ред.

21

ƒепресси€ Ц очень распространенное €вление: за год о симптомах депрессии сообщают более двух миллионов человек. ≈сли вы страдаете депрессией, постарайтесь разобратьс€, не вызвана ли она реальными проблемами? ¬ этом случае обратитесь за практической помощью и советом. √ражданское консультационное бюро предоставл€ет бесплатные советы по финансовым и юридическим вопросам, а Ђ—амарит€неї или ваши друзь€ помогут разобратьс€ с эмоциональными трудност€ми и научить с ними справл€тьс€. ’орошие советы нередко дает MIND, благотворительна€ организаци€, занимающа€с€ душевным здоровьем. ¬ одной из ее недавних брошюр о депрессии (MIND 1999. Depression Ц don't let it get you down. MIND and Pharmacy Healthcare; Mind Information, 15Ц19 Broadway, London E15 4BQ; Pharmacy Healthcare scheme, 1 Lambeth High Street, London SE1 7JN) утверждаетс€, что Ђтаблетки дл€ симптомов, а разговор Ц дл€ решени€ проблемї. ¬ы должны питатьс€ качественной, разнообразной пищей, поскольку в ней нуждаетс€ мозг, не употребл€ть искусственные органофосфаты (см. главу 6) и алкоголь в больших количествах. ≈сли у вас серьезна€ депресси€, обратитесь за медицинской помощью. ’от€ у современных антидепрессантов есть побочные эффекты, лучше иметь их, чем страдать от т€желой депрессии.

22

The Times, 7 February 1998.

23

Cox, Peter and Brusseau, Peggy, 1992. Superliving: A Beginner's Guide to Medspeak, Vermillion.

24

—крининг (от англ. screening, Ђпросеиваниеї) Ц общее название методов специальных проверок, обследований, примен€емых в медицине, биохимии, а также в бизнесе и т. п. ¬ медицине под скринингом понимают проведение простых и безопасных исследований больших групп населени€ с целью выделени€ групп риска развити€ той или иной патологии. Ц ѕримеч. ред.

25

Boots the Chemist, 1998. Breast Awareness Ц an essential guide. Be enlightened, not frightened. Published in association with the charity Breast Cancer Care.

26

Sunday Correspondent, 26 November 1989.

27

Alternative Therapy, British Medical Association, 1986.

28

New Scientist, 27 August 1987.

29

Vickers, A. and Zollman, C., 1999. ABC of complementary medicine: Acupuncture. British Medical Journal, 9 October, 973Ц976.

30

ƒополнительную информацию о контроле боли при раке, в том числе на поздних стади€х, см. в статье  этлин ћ. ‘оли в Scientific American, сент€брь, 1996.

31

Gerson, M., 1958. A Cancer Therapy: Results of Fifty Cases, Gerson Institute, California. Forbes, Alec, 1984. The Bristol Diet, Century.

32

Greenwald, P., 1996. Chemoprevention of Cancer. Scientific American, Special issue: What you need to know about Cancer, vol. 275, 3, pp. 96-100; and see also the World Health Organisation's International Agency for Research on Cancer website; http://who-pcc.iarc.fr/ and see also the British National Formulary, 1998.

33

Section on cytotoxic (cell poisoning) drugs in the British National Formularv, 1998.

34

Weinberg, Robert A., 1996. How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62Ц70.

35

Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563Ц566. Pollack, M. N., Huynh, H. T., and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100. Pollack, M. N., Polychronakos, C., Yousefi, S., and Richard, M., 1988. Characterisation of insulin-like growth factor-1 (IGF-1) receptors of human breast cancer cells. Biochem Biophy Res. Commun, 154, 1, 326Ц331.

36

Oliff, Alien, Gibbs, Jackson, B. and McCormick, Frank, 1996. New Molecular Targets for Cancer Therapy. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 144Ц149.

37

Weinberg, Robert A., 1996, How Cancer Arises. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 62Ц70.

38

Jain, R. K., 1994. Barriers to Drug Delivery in Solid Tumours. Scientific American, July, 271 (l), pp. 58Ц65.

39

Trichopoulos, Dimitros, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer. September 275, 3, 80Ц85.

40

Boots the Chemist, 1998. Breast Awareness Ц an essential guide, Be enlightened, not frightened. Published in association with the charity Breast Cancer Care.

41

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer Scientific American, Special Issue, What you need to know about Cancer. September, 275, 3, 80Ц85.

42

Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158Ц161.

43

http://www.who.int/nut/malnutrition_worldwide.htm

44

Cancer Incidence in Five Continents, 1997. Vol VII, published by the IARC (International Agency for Research on Cancer).

45

Cancer Incidence in Five Continents. 1997. Vol. VII, published by the IARC (International Agency for Research on Cancer).

46

Kliewer, E. V. and Smith, K. R., 1995. Breast cancer mortality among immigrants in Australia and Canada. Journal of Natl Cancer Institute, 87, 15, 1154Ц1161. See also Cancer Research Campaign, 1996, Factsheet 6.2, Breast Cancer Ц UK.

47

Campbell, T. C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615,

48

Rohan, T. E., McMichael, A. J. and Bagbursi, P. A., 1988. A population-based case control study of diet and breast cancer in Australia. Am. J. Epidemic, 128, 478Ц489; Howe, G. R., Hirobata, T., Hislap, T. G. and others. 1990. Dietary factors and risk of breast cancer, combined analysis of 12 case-control studies. J. Natl Cancer Inst., 8, 561Ц569; Willet, Walter C. and others, 1987. Dietary fat and the risk of breast cancer. N. Engl J. Med., 316, 22Ц28; Jones, D. Y., Schatzkin, A., Green, S. B. and others. 1987. Dietary fat and breast cancer in the National Health and Nutrition Examination Survey epidemiological follow-up study. J. Natl Cancer Inst., 79, 465Ц471.

49

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80Ц85.

50

Cramer, D. W. and others, 1989. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet, 2, 66Ц71.

51

Stocks, P., 1970. Breast cancer anomalies. British Journal of Cancer, 24, 633Ц643.

52

Maruchi, N. and others, 1977. Relation of food consumption to cancer mortality in Japan, with special reference to international figures. Gann, 1977; 68, 1-13.

53

Cox, Peter and Brusseau, Peggy, 1995. Life Points For Kids. Bloomsbury.

54

Statistical Abstracts of the US, 1994 edition.

55

Willett, W. C. and others, 1996. Strategies for Minimizing Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, 275:3, pp, 88Ц95.

56

Akre, James, ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

57

Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

58

Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

59

Akre, James, Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67; and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

60

Akre, James, Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

61

Akre, James Ed., 1989. Infant feeding: the physiological basis. WHO Bulletin, OMS Supplement, Vol. 67, and Lawrence, Ruth A., 1994. Breastfeeding: A guide for the medical profession. Fourth Edition, Mossby, USA.

62

American Academy of Pediatrics Committee on Nutrition (1992). The use of whole cows' milk in infancy. Pediatrics, 89, 1105Ц1109.

63

Anyon, C. P. and Clarkson, K. G., 1971. A cause of iron-deficiency anaemia in infants. N. Z. Med. J., 74, 24Ц25.

64

Clyne, P. S. and Kulczycki, A. 1991. Human breast milk contains bovine IgG. Relationship to infant colic? Pediatrics, 87(4), 439Ц444. Wilson, J. F., Lahey, M. E. and Heiner, D. C., 1974. Studies on iron metabolism. Further observations on cow's milk-induced gastrointestinal bleeding in infants with iron-deficiency anaemia. J. Pediatr., 84, 335Ц344.

65

Pugh, R. H., 1981. Allergy to Cows' Milk Protein. Health Visitor, Vol. 54, 231Ц233.

66

Scon, F. W., 1990. Cow milk and insulin-dependent diabetes mellitus: is there a relationship? Am. J. Clin. Nutr., 51, 489Ц491.

67

Bahna, S. L., 1987. Milk allergy in infancy. Ann Allergy, 59, 131.

68

Dunea, G., 1982. Beyond the Etheric. Br. Med. J., 285, 428Ц429.

69

Kretchmer, N., 1981. The Significance of lactose intolerance. In: Paige, D. M. and Bayless, T. M., Eds., Lactose Digestion: Clinical and nutritional implications, Johns Hopkins University Press.

70

Chiodini, R. J. and Hermon-Taylor, J., 1993. The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurisation. J. Vet. Diagn. Invest., 5, 629Ц631 and Grant, I. R., Ball, H. J., and Rowe, M. T., 1996. Inactivation of Mycobacterium paratuberculosis in cows' milk at pasteurisation temperatures. Appl. And Env. Microbiology, 62, 631Ц636.

71

The Institute of Food Science & Technology Position Statement, 1998. Food Science Of Technology Today. 12 (4), 223Ц228, September, http://www.ifst.org/hottop23.html

72

Financial Times for the weekend 20Ц21 November 1999.

73

The Institute of Food Science & Technology Position Statement. http://www.ifst.org/hottop2.html. Hard copies available from IFST, 5 Cambridge Court, 210 Shepherds Bush Road, London, W6 7NJ.

74

EU Directive 70/524 February 1999.

75

US FDA websites: http://vm.cfsan.fda.gov/~ear/m190-11.html; http://vm.cfsan.fda.gov/~ear/

76

Ingersoll, Bruce, 1990. Technology and Health: FDA Detects Drugs in Milk but Fails to Confirm Results. Wall Street Journal, 6 February p. 86; Ingersoll, Bruce, 1990. Politics and Policy: GAO Says FDA Can't Substantiate Claims About Milk. Wall Street Journal, 21 November p. A16; and Ingersoll, Bruce, 1990. Technology & Health: FDA Plans a Nationwide Test of Milk for Antibiotics, Other Drug Residues. Wall Street Journal, 28 December p. 10.

77

European Commission, Scientific Committee on Veterinary Measures relating to Public Health, 1999. Report on Public Health Aspects of the Use of Bovine Somatotropin, 15Ц16 March.

78

Cutwater, J. L. and others, 1997. Dairy Products and Breast Cancer: the IGF-1, estrogen and bGH hypothesis, Medical Hypotheses, 48, 453Ц461.

79

ƒƒ“ (дихлордифенилтрихлорэтан) Ц один из самых известных пестицидов.

80

The Guardian, 13 July 1999.

81

McCusker, R. H., 1998. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J. Dairy Sci., 81, 1790Ц1800.

82

√ормон роста, или соматотропин, структурно различаетс€ у разных видов животных, поэтому его называют согласно виду, которому он принадлежит, Ц бычий, свиной или, например, человеческий.

83

The Institute of Food Science & Technology Position Statement http://www.easynet.co.uk/ifst/hottop8a.htm

84

Eppard, P. J. and others, 1985. Effect of dose of bovine growth hormone on milk consumption: alpha-lactalbumin, fatty acids and mineral elements. J. Dairy Science Vol. 68 (11), pp. 3047Ц3054. See also Cohick, W. S. and others, 1992. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin. Endocrinology, 130(3), pp. 1508Ц1514.

85

Mepham, T. B. and others, 1994. Safety of Milk from Cows Treated with Bovine Somatotropin. Lancet, 334, November 19, 1445Ц1446 and Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

86

Simpson and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/75/0000077539.html

87

Miller, M. A., Hildebrand, J. R., White, T. C., Hammond, E. G., Madson, K. S., and Collier, R. J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science, 72, Supplement 1, 186Ц187.

88

Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393Ц1396.

89

Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science, 279, January.

90

Pollack, M. N., Huynh, H. T. and Lefebvre, S. P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br. Cancer Res. Treat, 22, 91-100.

91

Pollack, M. N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science, 279, 563Ц566.

92

Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk: A Prospective Study. Science, 279, January.

93

Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373Ц1375.

94

Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services, 26, 1, 173Ц185.

95

Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453Ц461.

96

Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week, Vol. 25, є 26, 14 July, pp. 4Ц5, Nutrition Week is published by the Community Nutrition Institute, 910 17th Street, N. W., Suite 413, Washington DC 20006.

97

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health Ц Outcome of discussions. http://europa.eu.mt/comm/dg24/health/sc/scv/out19_en.html

98

D'Ercole, J. A., Underwood, L. E. and Van Wyk, J. J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth. J. Pediatr., 90, 3, 375Ц381. See also Cullen, K. J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, vol. 50, pp. 48Ц53.

99

De Leon, D. D., Wilson, D. M., Powers, M. and Rosenfeld, R. G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors, 6, 327Ц336.

100

Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492Ц497.

101

Peyrat, J. P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer, 29A, 4, 492Ц497.

102

Musgrove, E. A. and Sutherland, R. I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur. J. Cancer, 29A, 16, 2273Ц2279.

103

Heldrin, C. N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell, 37:9, 20.

104

Macaulay, V. M., 1992. Insulin-like growth factors and cancer. Br. J. Cancer, 65, 311Ц320.

105

Underwood, L. E., D'Ercole, J. A. and Van Wyk, J. J., 1980. Somatomedin-C and the assessment of growth. Ped. Clin. N. Amer., 27, 4, 771Ц782, and Perdue, J. F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J. Biochem Cell Bio., 62, 1237Ц1245.

106

Outwater, J. L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453Ц461.

107

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health Ц Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html

108

Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.

109

Mepham, T. B. and Schonfield, P. N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

110

Challacombe. D. N. and Wheeler, E. E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet, 344, 17 September, p. 815.

111

Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Research, Jan 15, 55(2), 303Ц306.

112

Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science, 74, 167Ц201.

113

Xian, C., 1995. Degradation of IGFЦ 1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein. Journal of Endocrinology, 146, 2, 1 August, p. 215, and Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.

114

Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453Ц461.

115

Harasuchi, S., Good, R. A., Engelman, R. W. and Day, N. K., 1992. Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J. Cancer, 52, 923Ц933.

116

Clevenger, C, V., Chang, W. F., Ngo, W., Pasha, T. L., Montone, K. T. And Tomaszewski, J. E., 1995. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol., 146, 695Ц705.

117

Vonderhaar B. K., 1989. Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Lett, 47, 105Ц110.

118

http://www.shef.ac.uk/uni/academic/a-c/csi/1997/pir2.html

119

Lochnan, H. A. and others, 1995. Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol, 114, 91Ц99.

120

http://mammary.nih.20v/reviews/tumorigenesis/Vonderhaar001/slides/introduction.html

121

Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D'Angelo, G., Goffin, V., Weiner, R. I. and Martial, J. A., 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA, 96, 1246Ц1251.

122

http://www.eurekalert.org/releases/upmc-bcc061699.html

123

Lawrence R., 1994. Breastfeeding Ц A Guide to the Medical Profession, Fourth edition, Mossby, USA.

124

http://www.inter-medico.com/prolactin.html

125

Lawrence, R., 1994. Breastfeeding: A Guide for the Medical Profession. Fourth edition, Mossby, USA.

126

Poggi, S. H., Skinner, H., Catherine W. and others, 1998. Using scanning electron microscopy to study mineral deposits in breast tissues. American Mineralogist, 83, 1122Ц1126.

127

Lee, J. R., 1996. Natural Progesterone. John Carpenter Publishing, Oxfordshire, 113 pp.

128

Wolford, S. T. and Argoudelis, C. J., 1979. Measurement of Estrogens in Cow's Milk, Human Milk and Dairy Products. J. Dairy Sci., 62(9), 1458Ц1463.

129

Outwater, J. L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses, 48, 453Ц461.

130

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health Ц Outcome of discussions. 1999, Report on Public Health Aspects of the Use of Bovine Somarotropin. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html

131

Allen, N. E., and others, 2000. Hormones and Diet: Low Insulin-like Growth Factor-1 but Normal Bioavailable Androgens in Vegan Men. Brit. J. Cane., 83 (1), 95Ц97.

132

¬еганство (веганизм, англ. Veganism) Ц наиболее последовательна€ форма вегетарианства, строго вегетарианский образ жизни, исключающий использование продуктов, св€занных с эксплуатацией и убийством животных. ¬еганы Ц строгие вегетарианцы, исключающие из своего рациона все продукты животного происхождени€, включа€ м€со, рыбу, €йца, молоко, молочные продукты и иногда мед. ¬еганы не используют мех и кожу животных, выступают против убийства животных ради опытов и развлечений. Ц ѕримеч. ред.

133

Chan, J. C., and others, 1998. Plasma TGF-1 and Prostate Cancer Risk: A Prospective Study. Science 279, January.

134

Kradjian, R. D., 1994. Save Yourself from Breast Cancer, Berkley Books, New York.

135

 ормова€ патока, побочный продукт сахарного производства; сиропообразна€ жидкость темно-бурого цвета со специфическим запахом. ¬ —Ўј и  анаде используетс€ в кулинарии как сироп. Ц ѕримеч. ред.

136

Wright, K., 1996. A plea for prevention. Scientific American, September. (Inset p.99 in article by Greenwald 1996, see below ref. 20).

137

Collaborative Group on Hormonal Factors in Breast Cancer, 1996. Lancet, 347, 1713Ц1727.

138

http://www.who.int/nut/malnutrition_worldwide.html

139

The Times, 2 November 1999.

140

Riggs, B. L., Wahner, H. W., Melton, L. J. 3rd, Richelson, L. S., Judd, H. L. And O'Fallon, W. M., 1987. Dietary calcium intake and rates of bone loss in women. J. Clin. Invest., Oct, 80, 4, pp. 979Ц982.

141

Hegsted, D. M., 1986. Calcium and Osteoporosis. J. Nutr., 116, 2316Ц2319.

142

Kim, J. B., 1990. Fractured truths. Bestways v 18, n2, p. 26(7).

143

Kim, J. B., 1990. Fractured truths. Bestways v 18, n2, p. 26(7).

144

http://www.who.int/nut/malnutrition_worldwide.html

145

Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991.

146

Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Department of Health, 1991. P. 139, table 22.2.

147

Havaia, S. and Dwyer, J., 1988. Position of the American Dietetic Association: Vegetarian Diets Ц technical support paper. J. Am. Diet Assoc, 88:3 352Ц355.

148

Barnard, N., 1993. Food for life, Harmony Books.

149

'Research Advances in Osteoporosis', 1990. Conference by the National Osteoporosis Foundation, the National Institutes of Health, and the American Society of Bone and Mineral Research, Arlington, Virginia, USA February.

150

Heaney, R. P. and Weaver, C. M., 1990. Calcium absorbability from kale. Am. J. Clin. Nutr., 51, 656Ц657.

151

Breslau, N. A., Brinkley, L., Hill, K. D. and Pak, C. Y., 1988. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J. Clin. Endocrinol. Metab., Jan, 66, 1, pp. 140Ц146.

152

Heaney, R. P. and Recker, R. R., 1982. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J. Lab. Clin. Mod., Jan, 99, 1, pp. 46Ц55.

153

Pritchard, K. I. and others, 1996. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer, Journal of Clinical Oncology, vol. 14 (10), 2731Ц2738.

154

Gooderham, M. J., Adlercreutz, H., Sirpa, T. O., Wahala, K. and Holub, B. J., 1996. A Soy Protein Isolate Rich in Genistein and Daidzein and its Effects on Plasma Isoflavone Concentrations, Platelet Aggregation, Blood Lipids and Fatty Acid Composition of Plasma Phospholipid in Normal Men. J. Nutr., 126, 2000Ц2006.

155

Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96Ц99.

156

Kurzer, M. S. and Xu, X., 1999. Dietary Phytoestrogens. Annual Reviews of Nutrition, Vol. 17, pp. 353Ц381.

157

Shurtleff, William and Aoyagi, Akiko, 1975. The Book: of Tofu. Autumn Press Inc.

158

Kurzer, M. S. and Xu, X., 1999, Dietary Phytoestrogens. Annual Reviews of Nutrition Vol. 17, pp. 353Ц381.

159

UK Ministry of Agriculture, Fisheries and Food advice as reported in the Sunday Times, 1999.

160

Willet W. C., 1994. Micronutrients and cancer risk. Am. J. Clin. Nutr., 59, (suppl), 116 2S-5S. See also: Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996, Strategies for Minimising Cancer Risk. Scientific American, Special Issue, ЂWhat you need to know about Cancer, Septemberї, 275, 3, 88Ц95.

161

Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96Ц99.

162

Levy, J., Bosin, E., Feldman, B., Giat, Y., Milnster, Danilenko, M. and Sharoni, Y., 1995. Lycopene is more potent inhibitor of human cancer cell proliferation than either A-carotene or B-carotene. Nutr. Cancer, 24, 257Ц266.

163

Nagasawa, H., Mitamura, T., Sakamoto, S, and Yamamoto, K., 1995. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res. 15, 1173Ц1178.

164

Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996. Strategies for Minimising Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 88Ц95.

165

Ortega, R. M. and others, 1996. Functional and Psychic Deterioration in Elderly People may be aggravated by folate deficiency. J. Nutr., 126, 1992Ц1999.

166

Phipps, W. R., Martini, M. C., Lampe, J. W., Slavin, J. L. and Kurzer, M. S., 1993. Effect of fl ax seed ingestion on the menstrual cycle. J. Clin. Endocrinol. Metab., 77, 5, November, 1215Ц1219.

167

www.flax.com.fda

168

Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96Ц99.

169

Coghlan, Andy, 1999. Crunch Time for Cancer. New Scientist, 13 November, 264, 2212.

170

Pinto, J. T., Qiao, C. H., Xing, J., Rivlin, R. S., Protomastro, M. L., Weissler, M. L. and Hesion, W. D. W., 1999. Effects of garlic thioallylic derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am. J. Clin. Nutr. See also: Li, G., Qiao, C. H., Lin, R. I., Pinto, J., Osborne, M. F., and Tiwari, R. K., 1995, Antiproliferative effects of garlic constituents in cultured human breast cancer cells. Oncology Rpts., 2, 787Ц791.

171

www.3mistral.co.uk/garlic/cancer.htm; www.mskcc.org/rande/pharmacology/189.html

172

Greenwald, Peter, 1996. Chemoprevention of Cancer. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96Ц99.

173

Doll, R. and Peto, R., 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. New York: Oxford University Press.

174

Lang, T. and Clutterbuck, C., 1991. P is for Pesticides, Ebury Press, Random Century Group, 256 p.

175

McMichael, A. J., 1993. Planetary Overload Ц Global Environmental Change and the Health of the Species. Cambridge University Press.

176

Lang, T. and Clutterbuck, C., 1991. P is for Pesticides, Ebury Press, Random Century Group, 256 p.

177

http://www.radian.com/standards; http://ro-systemsnet/atrazine.html

178

Stevens and others, 1994. http://www-oem.ucdavis.edu~beaumont/Agrichem/herbicides/triazine/triazine.html Stevens, J. T. and Sumner, D. D., 1991. Herbicides, in Handbook of Pesticide Toxicology, Vol. 3. Classes of Pesticides, Toronto: Academic Press Inc, 1317Ц1408. See also Environmental Endocrine Disrupters: A handbook of property data, 1999.

179

http://who-pcc.iarc.fr/

180

Hambridge, K. M., Casey, C. E. and Krebs, N. F., 1986, Zinc, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W., Ed. Academic Press, Inc, London.

181

McCusker, R. H., 1998. Controlling Insulin-Like Growth Factor Activity and the Modulation of Insulin-Like Growth Factor Binding Protein and Receptor Binding. J. Dairy Sci, 81, 1790Ц1800.

182

Simpson and others. Effect of exogenous estradiol on plasma concentrations of somatotropin, insulin-like growth factor 1, insulin-tike growth factor-binding protein activity and metabolites in ovariectomised Angus and Brahman cows. http://www.nal.usda.gov/ttic/tektran/glimpse/data/000007/75/0000077539.html

183

The Globe and Mail 31 July 1999.

184

Hendler, S. S., 1990. The Doctors' Vitamin and Mineral Encyclopedia, Simon and Schuster, New York.

185

Ёстуарий Ц географический и геологический термин дл€ обозначени€ сильно расширенного усть€ реки. Ц ѕримеч. ред.

186

Hetzel, B. S., and Maberly, G. E., 1986. Iodine, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W., Ed. Academic Press, Inc, London.

187

Eskin, B. A., Shuman, R., Krouse, T., Merion, J. A., 1976. Rat mammary glandatypia produced by iodine blockade with perchlorate. Cancer Res, 35(9), 2332Ц2339. See also Eskin, B. A., 1978. In: Inorganic and Nutritional Aspects of Cancer. Schrauzer, G. N., ed., 293Ц304, Plenum Press, New York. This reference is quoted in Grouse, Robert G., Pories, Walter J., Bray, John T. and Mauger, Richard L., 1983. Geochemistry and Man: Health and Disease 1. Essential Elements. In: Applied Environmental Geochemistry. Thomton, I., Ed. London, Academic Press, 267Ц308.

188

Johnson, C., 1999, Environmental controls in iodine deficiency disorders (TDD), Earthworks, 9 November, p. 3, British Geological Survey.

189

Simopoulos, A. P., 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 54, 438Ц463.

190

Simopoulos, A. P., 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 54, 438Ц463. See also Fernandes, G. and Venkatraman, J. T., 1993. Role of omega-3 fatty acids in health and disease. Nutr. Res., 13, S19-S45.

191

Reported in the London Evening Standard, 17 March 1989. See also Willer W. C., 1994, Micronutrients and cancer risk. Am. J. Clin. Nutr., 59, (suppl), 1162S-1165S.

192

Hunter, David J. and Willett, Walter C., 1993. Diet and Body Build: Diet, Body Size and Breast Cancer, Epidemiologic Reviews, 15, 1, 110Ц132.

193

Ingram, A. J. and others, 1995. Effects of a Flaxseed and Flax Oil Diet in a Rat Ц 5/6 Renal Ablation Model. American Journal of Kidney Disease, February 25, 2, 320Ц329.

194

Obermeyer, W. R., Musser, S. M., Betz, J. M., Casey, R. E., Pohland, A. E. and Page, S. W., 1995. Chemical studies of phytoestrogens and related compounds in dietary supplements Ц fl ax and chaparral. Proceedings of the Society for Experimental Biology and Medicine. See also Obermeyer, W. R., Warner, C., Casey, R. E. and Musser, S., 1993, Flax seed lignans isolation metabolism and biological effects. Fed. Am. Soc. Exp. Biol. J., A863.

195

Dupont, J., White, P. J., Johnston, K. M. and others, 1989. Food safety and health effects of canola oil. J. Am. Coll. Nutr., 8, 360Ц375.

196

Kohlmeier, L, and others, 1997. Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer, Cancer Epidemiol. Biomarkers prev., 6, 9, 705Ц710.

197

Koletzko, B., 1992. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatr., 81, 302Ц306.

198

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80Ц85.

199

Forbes, Alec, 1984. The Bristol Diet, Century.

200

Ingram, A. J., Parbtani, A., Clark, W. F, Spanner, E., Huff, M. W., Philbrick, D. J. and Holub, B. J., 1995. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am. J. Kidney Dis., February, 25, 2, 320Ц329.

201

Lee, S. and others, 1999. Monitoring of Drinking Water in terms of Natural Organic Matter and Disinfection By-products. Proc. 2nd Intern. Symp. On Advanced Env. Monitoring, Kwangju, Korea.

202

Herrick, D., 1996. Cryptosporidium and Giardia: Should you be concerned? Water Well Journal, 50, 4, 49, 44Ц46.

203

Jankun, Jerzy, Seiman, Steven H., Swiercz; Rafal and Skrzypczak-Jankun, Ewa, 1997. Why drinking green tea could prevent cancer. Nature, 387, 15 June, p. 561 see also: Greenwald, Peter, 1996. Chemoprevention of Cancer, Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 96Ц99.

204

Jankun, Jerzy, Selman, Steven H., Swiercz, Rafal and Skrzypczak-Jankun, Ewa, 1997. Why drinking green tea could prevent cancer. Nature, 387, 15 June, p. 561.

205

Campion, K., 1986. Vegetarian Encyclopedia, Century Hutchinson Ltd, London.

206

Jankun, Jerzy, Selman, Steven H., Swiercz, Rafal and Skrzypczak-Jankun, Ewa, 1997. Why drinking green tea could prevent cancer. Nature, 387, 15 June, p. 561.

207

http://research.kib.ki.se/e-uven/public/51419.html

208

Lockwood, K., Moesgaard, S., Hanioka, T. and Fotkers, K., 1994. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol aspects Mod, 15, Suppis, 231Ц240. Lockwood, K., Moesgaard, S, and Folkers, K., 1994. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and Biophysical Research Communications, 199, 3, March 30, 1504Ц1508. Lockwood, K., Moesgaard, S., Yamamoto, T. and Folkers, K., 1995. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications, 212. 1, 172Ц177.

209

Gerhard Schrauzer, Ph. D., of the University of California cited in Better Nutrition, Nov, 1989, v 51, no. 11, p. 14 (2).

210

Redbook., April, 1989, v 172, n 6, p. 96 (5).

211

Spallholz, J. E., Stewart, J. R., 1989. Advances in the role of minerals in immunobiology. Center for Food and Nutrition, Texas Tech University, Lubbock 79409. Biol Trace Elem Res. Mar, 19 (3) pp. 129Ц151.

212

Archives of Environmental Health, September/October 1976.

213

Knekt, Paul, and others, 1988. Selenium Deficiency and Increased Risk of Lung Cancer. Abstract of paper read at the Fourth International Symposium on Selenium in Biology and Medicine, Tubingen, West Germany, July.

214

Reinhold, U., and others, 1988. Selenium deficiency and Lethal Skin cancer. Abstract of paper read at the Fourth International Symposium on Selenium in Biology and Medicine, Tubingen, West Germany, July.

215

Lockwood, K., Moesgaard, S., Hanioka, T., and Folkers, K., 1994. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med, 15, Suppls., 231Ц240. See also: Lockwood, K., Moesgaard, S. and Folkers, K., 1994. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and Biophysical Research Communications, 199, 3, 30 March, 1504Ц1508. See also: Lockwood, K., Moesgaard, S, Yamamoto, T. and Folkers, K., 1995. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications, 212, 1, 172Ц177.

216

—ледуйте инструкци€м производител€ и не превышайте рекомендуемую дозу.

217

Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, 1982. Geneva: World Health Organization, International Agency for Research on Cancer, 1972 Ц present. (Multivolume work). V29, p. 282. See also Osihi, Shinshi, 1990. Effects of phthalic acid esters on testicular mitochondrial functions in the rat Archives of Toxicology, March, V64 n 2, p. 143 (5).

218

Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158Ц161.

219

 огнитивна€ терапи€ Ц одно из направлений в психотерапии, опирающеес€ на положение об определ€ющей роли познавательных процессов (и в первую очередь мышлени€) в возникновении различного рода психологических проблем и психических отклонений (например, депрессии); бихевиористика Ц наука о поведении человека. Ц ѕримеч. ред.

220

Heason, P., Deep Relaxation available from 37 Tollerton Lane, Tollerton, Nottingham.

221

Based on Holland, J. C., 1996. Cancer's Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158Ц161.

222

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80Ц85.

223

Levy, Len, 1998, Biomed II: Exposure to low-level benzene, p. 76. In: Institute for Environment and Health, Annual Report. 100 pp.

224

Pearson, J. K., 2000. The Air Quality Challenge, American Society of Automotive Engineers and HMSO.

225

Ћав  энел (Love Canal) Ц построенное на месте бывшей химической свалки поселение, где обнаружилась повышенна€ частота врожденных дефектов и хромосомных аномалий; Ѕхопал Ц индийский город, в котором в результате аварийного выброса на химическом заводе компании Union Carbide в 1984 году погибло около 3 тыс€ч человек (и еще около 15 тыс€ч в последующие годы); —евезо Ц город на севере »талии, где в 1976 году на заводе ICMESA ∆еневской косметической фирмы Givaudan произошла взрывоподобна€ утечка химикатов, что вызвало необходимость массовой эвакуации жителей. Ц ѕримеч. ред.

226

North Atlantic Treaty Organisation, 1988. International Toxicity Equivalency Factor (I-TEF) method of risk assessment for complex mixtures of dioxins and related compounds. Pilot study on international information exchange on dioxins and related compounds. CCMS Report Number 176, Environmental Protection Agency, Washington DC, USA. Department of Health, 1995. Statement by the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment on the US EPA draft, health assessment document for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Dept of Health, London.

227

’лоракне Ц угреподобное поражение кожи, возникающее после длительного контакта с хлорированными углеводами. Ц ѕримеч. ред.

228

EPA Dioxin Reassessment Summary, 1994 4/94 Ц Vol. 1, CERI/ORD Publication Centre, USEPA.

229

MAFF, 1997. Dioxins and PCBs in retail cows' milk in England. Food Surveillance No. 136, December, Ministry of Agriculture, Fisheries and Food, London.

230

Tanabe, S., 1988. PCB Problems in the Future: Foresight from Current Knowledge. Environmental Pollution, 50, 5-28.

231

Department of the Environment, 1989. Dioxins in the Environment Pollution Paper, No. 27, HMSO, London.

232

MAFF, 1997. Dioxins and Polychlorinated Biphenyls in Fish Oil Dietary Supplements and Licensed Medicines. Food Surveillance Information Sheet, є 106, Ministry of Agriculture, Fisheries and Food, London.

233

MAFF, 1996. Dioxins In Human Milk. Food Surveillance Information Sheet, є 88, Ministry of Agriculture, Fisheries and Food, London.

234

MAFF, 1996. Polychlorinated Biphenyls in Food Ц UK Dietary Intakes. Food Surveillance Information Sheet, є 89, Ministry of Agriculture, Fisheries and Food, London.

235

Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.

236

Shin, R. J. and others, 1999. Development of a bioassay system for identification of Endocrine Disrupters. Proc. 2nd Intern. Symp. On Advanced Env. Monitoring, Kwangju, Korea.

237

Soto, A. M. and others, 1992. An in culture bioassay to assess the estrogenicity of xenobiotics. In: Chemically-induced alterations in sexual and functional development. The wildlife/ human connection. Vol. 21, Colborn T. C, Clement ed., Princeton Scientific Publishing, 295Ц309. See also: Soto, A. M. and others, 1995. The E-SCREEN assay as a tool to Identify estrogens: An update on estrogenic environmental pollutants. In: Estrogens in the Environment, Environmental Health Perspectives, 113Ц122.

238

Davis, Devra Lee, Axelrod, Deborah, Osborne, Michael P. and Telang, Nitin T., 1997. Environmental influences on Breast Cancer Risk, World Resources Institute, Washington, DC, USA, Science and Medicine. May/June.

239

Colborn, T., Dumanoski, D. and Myers, J. P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.

240

Dyson, T., 1999. Prospects for feeding the world. British Medical Journal, 319, 988Ц991.

241

Reuters, 8 October 1998.

242

McMurry, Laura M., Oethinger, Margaret, Levy, Stuart B., 1998. Triclosan targets lipid synthesis. Nature, 394, 6693, 531Ц532.

243

Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80Ц85.

244

Campbell, T. C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615.

245

»нвазивна€ процедура (от invado Ц Ђвхожу внутрьї) Ц медицинска€ процедура, св€занна€ с проникновением через естественные внешние барьеры организма (кожа, слизистые оболочки). ѕримером простейшей инвазивной процедуры €вл€етс€ люба€ инъекци€, самой сложной Ц хирургическа€ операци€. »нвазивные процедуры могут примен€тьс€ также дл€ диагностики. Ц ѕримеч. ред.

246

Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes. October.

247

Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October.

248

Association of University Teachers. Efficiency Gains or Quality Losses? 1996 (Based on DfEE and Welsh Office figures).

249

Bok, D., 1990. In: Universities and the Future of America , Duke University Press, Durham NC.

250

Glantz, S. A., 1996. Times Higher Education Supplement, 6 September, p. 15. and Glantz, S. A., Slade, J., Bero, L. A., Hanauer, P. and Barnes, D. E., 1996. The Cigarette Papers, University of California Press.

251

Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy Ц a Faustian contract. Industry and Higher Education, April, 85Ц90.

252

Packham, D. E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academyЦ a Faustian contract. Industry and Higher Education, April, 85Ц90.

253

Jasanoff, S., 1997. Civilization and madness: the great BSE scare of 1996. Public Understand. Sci. 6, 221Ц232.

254

McMichael, A. J. and Powles, J. W., 1999. Human numbers, environment, sustainability and health. British Medical Journal, 319, 9 October, 977Ц980.

255

www.nlm.nih.gov/medlineplus/ency/article/002919.htm

256

McKenna, Claire, 2002. UK has highest reduction in deaths from lung and breast cancer. BMJ, 325, 63.

257

Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678Ц679.

258

Anon, 2006. Screening for breast cancer. BMJ, 332, 499Ц500.

259

www.nlm.nih.gov/medineplus/ency/article/002919.htm

260

e. g. Baum, M., 2000. Survival and reduction in mortality from breast cancer Ц Impact of mammographic screening is hot clear (Letter). BMJ, 321, 1470.

261

Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.

262

Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.

263

Josefson, Deborah, 2002. Breast self-examination does not improve cancer survival. BMJ, 325, 793.

264

Zackrisson S. and others, 2006. Rare of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial; follow up study. BMJ, 332, 689Ц692.

265

Anon, 2006. Screening for breast cancer. BMJ, 332, 499Ц500.

266

Symonds, R. Paul, 2002. Cancer biology may be more important than diagnostic delay. BMJ, 325, 774.

267

Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.

268

www.cancerscreening.nhs.uk/breastscreen

269

White, Caroline, 2002. 'Unacceptable' errors found in breast screening process. BMJ, 324, 933.

270

UK National Radiological Protection Board, www.nrpb.org/radiation_topics/risks/exposure.htm

271

Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678Ц679.

272

√истерэктоми€ (hysterectomy) Ц хирургическое удаление матки. Ц ѕримеч. ред.

273

www.well-connected.com/rreports/doc06full.html

274

www.well-connected.con'i/rreports/doc06full.html

275

Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I. Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T. W., and Bacus, S. S., 2002. Cyclin E and Survival in Patients with Breast Cancer. N. Engl. J. Med., 347, 1566Ц1575.

276

Yancik, R. and Ries, L. A., 1994. Cancer in older persons. Magnitude of the problem Ц how do we apply what we know? Cancer, 74 (7 Suppl), 1995Ц2003.

277

Silliman, R. A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, W. B. and Lyman, G. H., Comprehensive geriatric oncology. Amsterdam: Harwood.

278

Welch, H. G., Albertson, F. C., Nease, R. F., Bubolz, T. A. and Wasson, J. H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577Ц584.

279

Holmes, F. F., 1994. Clinical course of cancer in the elderly. Cancer Control, 1, 108Ц114.

280

Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S. and others, 1994. Relationship of patient age to pathological features of the tumor and prognosis for patients with stage I or II breast cancer. J. Clin. Oncol., 12, 888Ц894.

281

Balducci, Lodovico and Phillips, D. Melissa. 1998. Breast cancer in older women. American Family Physician. October 1, 1998. www.aafp.org/afp/981001ap/balducci.html

282

www.well-connected.com/rreports/doc06full.html

283

Medical Report: Prostate Cancer. ICON, 2002, 1 (5), 8Ц10.

284

Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.

285

http://www.nccn.org/paticnt_gls/_english/_prostate/

286

http://www.nccn.org/patient_gls/_english/_prostate/

287

Hart, D. and Wall, 2004. UK population dose from medical examinations. European Journal of Radiology, 50 (3), 285Ц291, Brenner, D. I. and others, 2001. CT scanning of children has been calculated 10 increase their lifetime risk of cancer. American Journal of Roentology, 176, 289Ц296.

288

http://www.nccn.org/patient_gls/_english/_prostate/

289

http://www.cancer.org

290

Spurgeon, David, 2003. Advanced scanning techniques help doctors stage prostate cancer. BMJ, 326, 1418.

291

New England Journal of Medicine, 2003, 348, 2491Ц2499.

292

http://www.nccn.org/patient_gls/_english/_prostate/

293

Fisher, B. and others, 2002. Twenty year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine, 347 (16), 1233Ц1241.

294

Fisher, B., Bryant, J., Dignam, J. J., Wickerham, D. L., Mamounas, E. F., Fisher, E. R., Margolese, KG., Nesbitt, L., Paik, S., Pisansky, T. M., Wolmark, N., 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol., 20 (20), 4141Ц4149; www.ncbi.nlm.nih.gov;80

295

Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J. H. and Wolmark, N., 2002. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med., 347 (16), 1233Ц1241; www.ncbi.nlm.nih.gov;80

296

Gottlieb, Scott. Lumpectomy is as effective as mastectomy for breast cancer. BMJ, 325, 921.

297

www.nlm.nih.gov/medlineplus/ency/article/002919.htm

298

www.nlm.nih.gov/medlineplus/ency/article/002919.htm

299

www.cancer.org/docroot/cri/content/cri_2_6x_breast_reconstruction_after_mastectomy_5.asp

300

Bartelinkh and others, 2001. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England J. Med., 345 (19), 1378Ц1387.

301

http://cis.nci.nih.gov/fact/7_16.htm

302

Morrow, Monica and Gradishar, William, 2002. Recent Development: Breast Cancer. BMJ, 324, 410Ц414.

303

Coombes, R. C. and others, 2006. American Society of Clinical Oncology, Annual Meeting, Atlanta Georgia, June 2006.

304

Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ, 325, 1051Ц1052.

305

www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm

306

www.herceptin.com/herceptin/physician/pi.htm

307

Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ, 332Ц443.

308

Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118Ц1120.

309

Daily Mail, Monday, 9 October, 2006.

310

www.ahrq.gov/news/press/pr2002/brchempr.htm

311

www.ahrq.gov/news/press/pr2002/brchempr.htm

312

http://cis.nci.nih.gov/fact/7_16.htm

313

Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ, 325, 7.

314

http://cis.nci.nih.gov/fact/7_16.htm

315

Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ, 324, 1539

316

www.gene.com/gene/products/information/oncology/herceptin; www.herceptin.com/herceptin/physician/pi.htm

317

http://cis.nci.nih.gov/fact/7_45.htm

318

New Scientist, 20 January, 2007.

319

Editorial, New Scientist, 31 March, 2007.

320

Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ, 324, 1113.

321

Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ, 325, 269Ц271.

322

www.cancer.gov

323

Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99Ц1136: www.cancer.gov/cancerinfo/chemorherapy-and-you

324

Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ, 332, 162Ц181.

325

Allison, R. and others, 2006. Photodiagnosis and photodynamic therapy, 3, 139Ц146.

326

Fritsch, C. and Ruzika, T., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.

327

јбл€ци€ (лат. ablatio Ц отн€тие) Ц специфическое хирургическое вмешательство; абл€ци€ подразумевает под собой выжигание или выпаривание дисфункциональной или патологически измененной ткани с использованием лазера, радиочастотного аппарата, тока или химии; также данна€ операци€ может проводитьс€ классическим хирургическим вмешательством. Ц ѕримеч. ред.

328

Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.

329

Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.

330

Ernst, E., 2003. Herbal medicines put into context. BMJ, 327, 881Ц882.

331

Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.

332

Dyer, Owen, 2003. Aspirin could be used to prevent cancer. BMJ, 326, 565.

333

Flower, Rod, 2003. What are all the things that aspirin does? BMJ, 327, 572Ц573.

334

UK limits use of aspirin by under 16s. BMJ, 2002, 324, 1294.

335

Astralagus. ICON, 2002, 1 (3), 23.

336

Bartram, T., 1998. Bartram's encyclopedia of herbal medicine. Robinson publishing.

337

Campbell, T. C. and Campbell, T. M., 2006. The China Study. Benbella Books.

338

–ейки Ц вид комплементарной медицины, в котором используетс€ техника так называемого исцелени€ путем наложени€ рук. Ц ѕримеч. ред.

339

Greenwald, Peter, 2002. Cancer chemoprevention. BMJ, 324, 714Ц718.

340

Clarke, M.F. and Becker, M.W., 2006. Stem cells: the real culprits in cancer? Scientific American, July 2006, 53Ц59.

341

Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl

342

Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, V.W., 1990. Harper's Biochemistry. Appleton and Lange Norwalk, CT, p. 653.

343

Woolf, Neville, 1998. Pathology, Basic and Systemic. W.B. Saunders Publishing Co., Chapter 28, p. 274, Figure 28.

344

www.intouchlive.com/cancergenetics/onco.htm

345

Ludwig, T., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tumorigenesis in mice carrying a truncating BRCA1 mutation. Genes and Development, Vol. 15 (10), 1188Ц1193.

346

Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics, Vol. 22 (1), 37Ц43.

347

Paull, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Gellert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA , Vol. 98 (11), 6086Ц6091.

348

Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, B., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics, 12, 303Ц308; www.mc.vanderbilt.edu/cancer/research/roster/jensen.html

349

Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals. Nature Genetics, 11, 198Ц200; http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html

350

Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics, 14, 185Ц187; Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Vrody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P. Jhanwar, S., Golgar, D., Ostrer, H. and Offit, K., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 %. Nature Genetics, 14, 188Ц190; http://rex.nci.nih.gov/massmedia/backgrounders/ashkenazi.html

351

www.mercola.com/2002/apr/27/sv40.htm

352

Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute, 35, 2031Ц2038.

353

Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine. Churchill Livingston.

354

Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine. Churchill Livingston.

355

Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer. Proceedings of the Royal Society of Edinburgh , 95B, 231Ц237.

356

Miller, W. R., 1997. Aromatase inhibitors and breast cancer. Cancer Treatment Reviews, 23, 113Ц131.

357

Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours. Cancer Research, 42, 359Ц362.

358

Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer. Journal of Steroid Biochemistry, 23, 1169Ц1172.

359

Miller, W.R. and Langdon, S.P., 1997. Hormonal, growth factor and cytokine control of breast cancer. In: Biology of Female Cancers, pp. 43Ц60. Langdon, S,P., Miller, W.R. and Berchuck, A. (editors). New York: CRC Press.

360

Miller, W.R., 1991. Oestrogens and breast cancer: biological considerations, British Medical Bulletin, 47, 470Ц483.

361

Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst, 92, 1472Ц1489.

362

Rose, Steven, with Mileusnic, Radmila, 1999. The Chemistry of Life. Fourth (revised) edition. Penguin Books.

363

Voet, Donald and Voet, Judith, 1995. Biochemistry. Second edition. John Wiley & Sons, Inc.

364

Jiang, Wen G., Matsumoto, Kunio and Nakamura, Toshikazu (editors), 2001, Growth Factors and their Receptors in Cancer Metastasis. Dordrecht: Kluwer Academic Publishers.

365

Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92, 1472Ц1489.

366

Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92, 1472Ц1489.

367

www.ucop.edu/srphome/bcrp/progressreport/abstracts/innov/3CB-0186.html

368

Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 92, 1472Ц1489.

369

www.preventcancer.com/pdf/InsulinGrowth266.html

370

www.dep.iarc.fr/globocan/database.pdf

371

Ёту обновленную таблицу нельз€ напр€мую сравнивать с более ранней версией, приведенной выше, поскольку ¬ќ« изменила группировку и методы стандартизации по возрасту. »нформаци€ из √онконга включена в статистику  ита€.

372

WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors), www.dep.iarc.fr/globocan/database.pdf

373

American Cancer Society. Modelled data: cancer facts and figures, 2006.

374

www.cancerresearchuk.org

375

www.cancerresearchuk.org

376

www.cancerresearchuk.org

377

Pike M.C., Kolonel, L.N., Henderson, B.E., Wilkens, L.R., Hankin J.H., Feigelson, H.S., Wan, P.C., Stram, D.O. and Nomura, A.M., 2002. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev., 11 (9), 795Ц800.

378

www.hawaii.edu/crch/ProfileKolonel.htm

379

www.yoursurgery.com/ProcedureDetails.cfm?BR=3&Proc=36

380

American Cancer Society. Modelled data: cancer facts and figures, 2006.

381

Worldwide Cancer Mortality Statistics, ASR(w) for Annual Mortality per 100 000 by sex and age group. http://www.depd.iarc.fr/who/menu.htm

382

Yancik, R. and Ries, L.A., 1994. Cancer in older persons. Magnitude of the problem: how do we apply what we know? Cancer, 74 (7 Suppl), 1995Ц2003.

383

Silliman, R.A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, W.B. and Lyman, G.H. Comprehensive geriatric oncology. Amsterdam: Harwood.

384

Welch, H.G., Albertson, P.O., Nease, R.F., Bubolz, T.A. and Wasson, J.H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577Ц584.

385

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

386

Dobson, R., 2006. Breast cancer incidence rises in contaminated areas 10 years after explosion at Chernobyl reactor. BMJ, 332, 567.

387

Jakes, R.W. and others, 2002. Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiological Biomarkers Prev., 11, 608Ц613.

388

www.cancer.org; www.cancer.org/docroot/CRI/content/CRl_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp

389

Dobson, R., 2006. Diethylstilbestrol increase risk of breast cancer death. BMJ, 333, 64.

390

www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_male_breast_cancer_28.asp

391

www.dep.iarc.fr/globocan/database.pdf

392

WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors). www.dep.iarc.fr/globocan/database.pdf

393

Campbell, T.C., and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59, Suppl., 11 535-11 615.

394

Jakes, Rupert W., Duffy, Stephen W., Ng, Fook-Cheong, Gao, Fei, Ng, Eng-Hen, Seow, Adeline, Lee, Hin-Peng and Yu, Mimi C., 2002. Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 11, 608Ц613.

395

Statistical Abstracts of the US, 1994 edition.

396

T. Colin Campbell, quoted in www.milksucks.com/osteo.html; Robbins, John, 1987, A Diet for a New America. Stillpoint Publishing; McDougall, John, 2000. The McDougall Program for Women; Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. Virgin Books.

397

FAO (англ. Food and Agriculture Organization) Ц продовольственна€ и сельскохоз€йственна€ организаци€ ќќЌ. Ц ѕримеч. ред.

398

IARC Cancer Epidemiology Database. GLOBOCAN 2000, Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P., and Parkin, D.M. (editors), www.dep.iarc.fr/globocan/database.pdf

399

Frassetto, L.A., Todd, K.M., Morris, R.C., Jr and Sebastian, A., 2000. Worldwide incidence of hip fracture in elderly women: relation to consumption of animal and vegetable foods. Journal of Gerontology: Medical Sciences, 55A. 10, M585-M592.

400

Jakes, Rupert W., Duffy, Stephen W., Ng, Fook-Cheong, Gao, Fei, Ng, Eng-Hen, Scow, Adeline, Lee, Hin-Peng and Yu, Mimi C., 2002. Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 11, 608Ц613.

401

Pringle, H., 1998. Neolithic agriculture: reading the signs of ancient animal domestication. Science. 282, 1448.

402

Thomas M and others, 2007, Proc. Nat. Acad. Sci.

403

Latham, M.C., 1997. Human nutrition in the developing world, Rome, 1997. FAO Food and Nutrition Series є 29, Cornell University, Ithaca, N Y.

404

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

405

AbuGhazaleh, A.A. and others, 2004. CLA increases in milk when cows fed fish meal and extruded soybeans for an extended period of time. Journal of Dairy Science, 87 (6), 1758Ц1766.

406

Petit, H.V., 2002. Digestion, milk production, milk composition, and blood composition of dairy cows fed whole fl ax seed. Journal of Dairy Science, 85 (6), 1482Ц1490.

407

Wahle, K.W. and others, 2004. CLAs: are they beneficial or detrimental to health? Progress in Lipid Research, 43 (6), 553Ц587.

408

Willett, W.C, and Stampfer, M.J., 2007. Rebuilding the food pyramid. Scientific American, Special edition on diet and health, February 2007, 12Ц21.

409

The Royal Society, 2000. Endocrine-disrupting chemicals. Document 06/00. The Royal Society.

410

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

411

Qin, L.Q. and others, 2004. Estrogen: one of the risk factors in milk for prostate cancer. Medical Hypotheses, 62 (1), 133Ц142.

412

Hartman, S. and others, 1998. Natural occurrence of steroid hormones in food. Food Chemistry, 62, 7-20.

413

Buder, J., 2006. White lies. Vegetarian and Vegan Foundation.

414

Ganmaa, D. and Sato, A., 2005. Possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses, 65 (6), 1028Ц1037.

415

DEFRA, 2005. Agriculture in the UK, 2004. Norwich, UK: HMSO.

416

Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J. Clin. Nutr., 59, Suppl., 11 535-11 615.

417

Charatan, Fred, 2003. Book Review: Fat Land: How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.

418

Charatan, Fred, 2003. Book Review: Fat Land: How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.

419

Charatan, Fred, 2003. Book Review; Fat Land; How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.

420

Grosvenor, C.E. and others, 1992. Hormones and growth factors in milk. Endocrine Reviews, 14 (6), 710Ц728.

421

http://www.dhn.csiro.au/crctissue.html

422

http://www.13.waisays.com/cancer2.htm

423

le Huerou-Luron, I. and others, 1998. Source of dietary protein influences kinetics of plasma gut regulatory peptide concentration to feeding in preruminant calves. Comparative Biochemistry and Physiology: A Ц Molecular and Integrative Physiology, 119 (3), 817Ц824.

424

Koldovski, O. and others, 1995. Milk-borne hormones: possible tools of communication between mother and suckling. Physiological Research, 1995, 44 (6), 349Ц351, Koldovsky, O. and others, 1994. Hormonally active peptides in human milk. Acta Paediatrica Suppl., 402, 89Ц93; Lehy,T. and others, 1990. Promoting effect of bombesin on the cell proliferation in the rat endocrine pancreas during the early post natal period. Regulatory Peptides, 27 (1), 87Ц96; Pollack, P.F., 1989. Effects of enterallyЦ and parenterally-administrated bombesin on intestinal luminaltryptic activity and protein in the suckling rat. Experienta, 45 (4), 385Ц388; Lazarus, L.H. and others, 1986. An immunoreactive peptide in milk contains bombesin-like bioactivity. Experienta, 42 (7), 822Ц823; Jahnke, G.D. and others, 1984. A bombesin immunoreactive peptide in milk. Proc. Natl. Acad. Sci. USA, 81 (2), 578Ц582.

425

Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides in human milk. Am. J. Clin. Nutr., 51 (6), 985Ц990.

426

Burns, D.M. and others, 1999. Breast cancer cell-associated endopeptidase EC24.11 modulates proliferative response to bombesin, British Journal of Cancer, 79 (2), 214Ц220; Bold, R.J, and others, 1998. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptor status. Anticancer Research, 18 (16A), 4051Ц4056; Miyazaki, M. and others, 1998. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-11 and RC-3095. European Journal of Cancer, 34 (5), 710Ц717; Nelson, J, and others, 1991. Bombesin stimulates proliferation of human breast cancer cells in culture. Br. J. Cancer, 63 (6), 933Ц936; Giacchetti, S. and others, 1990. Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J. Cancer, 46 (2), 293Ц298; Weber, C.J. and others, 1989. Gastrin-releasing peptide, calcitonin gene-related peptide, and calcitonin-like immuno-reactivity in human breast cystfluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines. Surgery, (6), 1134Ц1139 (disc. 1139Ц1140).

427

Markwalder, R. and others, 1999. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Research, 59 (5), 1152Ц1159; Festuccia, C. and others, 1998. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer, 75 (3); 418Ц431: Krongrad, A. and others, 1997. Endopeptidase 24.11 activity in the human prostate cancer cell lines LNCaP and PPC-1. Urological Research, 25 (2), 113Ц116; Jungwirth, A. and others, 1997. LHRH antagonist Cetrolix (SB-75) and bombesin-antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate, 32 (3), 164Ц172; Larran, J. and others, 1996. In vitro characterization of bombesin and calcitonin on the proliferation of PC3, DK145 and LNCaP cancer prostatic cell lines. International Journal of Developmental Biology, 1996 (Suppl. 1), 275SЦ276S; Aprickian, A.G. and others, 1996. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostatic cancer cells. Journal of Molecular Endocrinology, 16 (3), 297Ц306; Bologna, M. and others, 1989. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer, 63 (9), 1714Ц1720; Wasilenko, W.J. and others, 1996. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int J. Cancer, 68 (2), 259Ц264.

428

Takeyama, M. and others, 1989. Enzyme immunoassae of gastrin-releasing, peptide (GRP)-like immunoreactivity in milk. Int. J. Pept. Protein Res., 34 (1), 70Ц74.

429

Ducroc, R. and others, 1995. Immunoreactive substance P and calcitonin-gene-related peptide (CGRP) in rat milk and in human milk and infant formula's. Am. J. Clin. Nutr., 62 (3), 554Ц558.

430

Lembeck, F. and others, 1979. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Arch. Pharmacol., 310 (2), 175Ц183.

431

Khare, V. K. and others, 1998. The neuropeptide/mast cell secretagogue substance F is expressed in cutaneous melanocyticlesions. Journal of Cutaneous Pathology, 25 (1), 2-10.

432

Ducroc, R. and others, 1995. Immunoreactive substance P and calcitonin-gene-related peptide (CGRP) in rat milk and in human milk and infant formula's. Am. J. Clin. Nutr., 62 (3), 554Ц558.

433

Faulkner, A., 1998. Insulin-like growth factor 1 concentrations in milk and plasma after growth hormone treatment. Biochemical Society Transactions, 26 (4), 386; Silanikove, N. and others, 1998. Metabolic and productive response of dairy cows to increased ion supplementation at early lactation in warm weather. Journal of Dairy Research, 65 (4), 529Ц543; Ginjala, V. and others, 1998. Determination of transforming growth factor-beta 1 (TGF-beta 1) and insulin-like growth factor-1 (IGF-1) in bovine colostreum samples. Journal of Immunoassay, 19 (2Ц3), 195Ц207; Schober, D.A. and others, 1990. Perinatal expression of type 1 IGF receptors in porcine small intestine. Endocrinology, 126 (2), 1125Ц1132.

434

Rao, R.K. and others, 1998. Luminal stability of insulin-like growth factor-1 and -2 in developing rat gastrointestinal tract. Journal of Pediatric Gastroenterology and Nutrition, 26 (2), 179Ц185.

435

Parisot, J.P. and others, 1999. Altered expression of the insulinlike growth factor-1 receptor in a tamoxifen-resistant human breast cancer cell line. Br. J. Cancer, 79 (5Ц6), 693Ц700; Sciacca, L. and others, 1999. Insulin receptor activation by insulin-like growth factorЦ 2 in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene, 18 (15), 2471Ц2479; Grothey, A. and others, 1999. The role of insuline-like growth factor and its receptor in cell growth transformation, apoptosis, and chemoresistance In solid tumors. Journal of Cancer Research and Clinical Oncology, 125 (3Ц4), 166Ц173; Perks, C. M. and others, 1999. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor-1 (IGF-1) in human breast cancer cell lines. Br. J. Cancer, 79 (5Ц6), 701Ц706; de Cupis, A. and others, 1998. Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line; comparison between early and late cultures. In Vitro Cellular and Developmental Biology Ц Animal, 34 (10), 836Ц843; Kobari, M. and others, 1998. The inhibitory effect of an epidermal growth factor receptor specific tyrokinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF-1. International Journal of Pancreatology, 24 (2), 85Ц95; Gooch, J.L. and others, 1998. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res., 58 (18), 4199Ц4205; Choki, I. and others, 1998. Osteobiast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Anticancer Res., 18 (16A), 4213Ц4224; Jackson, J.G. and others, 1998, Insulin receptor substrate-1 is the predominant signalling molecule activated by insulin-like growth factor-1, insulin, and interleukinЦ 4 in estrogen receptor-positive human breast cancer cells. Journal of Biological Chemistry, 273 (16), 9994-10 003; Westley, B.R. and others, 1998. Interactions between the oestrogen and IGF signalling pathways in the control of breast epithelial cell proliferation. Biochemical Society Symposium, 63, 35Ц44; Surmacz, E. and others, 1995. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clinical Cancer Research, 1 (11), 1429Ц1436.

436

Untersasser, G. and others, 1999. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors. Experimental Gerontology, 34 (2), 275Ц287; Xu, Z.D., 1999. Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-2 ribonucleic acid in vitro and in prostate cancer cells. Endocrinology, 140 (5), 2134Ц2144; Marelli, M.M. and others, 1999. Luteinizing hormone-releasing hormone agonists interfere with the antagonic activity of the insulin-like growth factor system in androgen-dependent prostate cancer cells. Endocrinology, 140 (1), 329Ц334; Larnharzi, N. and others, 1998. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DY-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factorЦ 2 in tumors. Proc. Natl. Acad. Sci. USA, 95 (15), 8864Ц8868; Wang, Y.Z. and others, 1998. Sex hormone-induced prostatic carcinogenesis in the noble rat; the role of insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in the development of cancer. Prostate, 35 (3), 165Ц177.

437

He, Y., 1999. Comment on the Association between InsulinLike Growth Factor-1 (IGF-I) and Bone Mineral Density: Further Evidence Linking IGF-I to Breast Cancer Risk. Journal of Cellular Endocrinology and Metabolism, 84, 1760.

438

Perks, C. M. and Holly, J.M.P., 2000, Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 5, 75Ц84.

439

Murphy, M.S. and others, 1998. Growth factors and the gastrointestinal tract. Nutrition, 14 (10), 771Ц774; Buts, J.F., 1998, Bioactive factors in milk. (in French.) Archives de Pediatrie, 5 (3), 298Ц306.

440

Shen, W.H. and others, 1998. Stability and distribution of orally administered epidermal growth factor in neonatal pigs. Life Sciences, 63 (10), 809Ц820; Rao, R.K. and others, 1998. Bovine milk inhibits proteolytic degradation of epidermal growth factor in human gastric and duodenal lumen. Peptides, 19 (3), 495Ц504; McCuskey, R.S. and others, 1997. Effect of milkborne epidermal growth factor on the hepatic microcirculation and Kupfer cell function in suckling rats. Biology of the Neonate, 7 (3), 202Ц206; Oguchi, S. and others, 1997. Growth factors in breast milk and their effect on gastrointestinal development. Chang Hua Min Kuo Hsiao Ehr Ko I Hsuek Tsa Chih, 38 (5), 332Ц337.

441

Salomon, D.S. and others, 1999. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays, 21 (1), 61Ц70; Chou, Y.C. and others, 1999. Induction of mammary carcinomas by N-methyl-N-nitrosurea in ovariectomized rats treated with epidermal growth factor. Carcinogenesis, 20 (4), 677Ц684; Kurtz, A. and others, 1998. Local control of mammary gland differentiation: mammary-derived growth inhibitor and pleiotrophin. Biochemical Society Symposium, 63, 51Ц69; Taylor, M.R. and others, 1997. Lactadherin (formerly BA46); a membrane-associated gycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA and Cell Biology, 16 (7), 861Ц869.

442

Zhau, H.J. and others, 1996. Androgen-depressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A., 93 (26), 15 152-15 157.

443

Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.

444

www.prostatepointers.org/cmyers/pf0696.html

445

Gaull, G.E. and others, 1985. Significance of growth modulators in human milk. Pediatrics, 75 (2), 142Ц145.

446

Delgrange, E. and others, 1997. Sex related differences in the growth of prolacrinomas: a clinical and proliferation marker study. Journal of Clinical Endocrinology and Metabolism. 82 (7), 2102Ц2107.

447

Vonderhaar, B.K., 1998, Prolactin: The forgotten hormone of human breast cancer. Pharmacology and Therapeutics, 79 (2), 169Ц178; Das, R. and others; 1996. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene, 13 (6), 1139Ц1145; Mershon, J, and others, 1995. Prolactin is a local growth factor in rat mammary tumors. Endocrinology, 136 (8), 3619Ц3623; Ginsberg, E. and others, 1995. Prolactin secretion by human breast cancer cells. Cancer Res, 55 (12), 2591Ц2595; Fuh, G. and others, 1995. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol Chem, 270 (22), 13 133-13 137.

448

Leav, I. and others, 1999. Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions. American Journal of Pathology, 154 (3), 863Ц870; Horti, J. and others, 1998. A phase 2 study of bromocriptine in patients with androgen-independent prostate cancer. Oncology Reports, 5 (4), 893Ц896; Franklin, R.B. and others, 1997. Prolactin regulation of mitochondrial aspartate aminotransferase and proteinkinase C Molecular and Cellular Endocrinology, 127 (1), 19Ц25; Janssen, T. and others, 1996. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer, 77 (1), 144Ц149; Janssen, T. and others, 1995. Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer, (frans) Acta Urol Belg, 63 (1), 7-14; Oliver, R.T. and others, 1995. New directions with hormone therapy in prostate cancer: possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy. Eur. J. Cancer, 31A (6), 859Ц860; Rana, A. and others, 1995. A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate. Eur. J. Cancer, 31A (6), 871Ц875.

449

Hinuma, S. and others, 1998. A prolactin-releasing peptide in the brain. Nature, 393 (6682), 272Ц276.

450

Smith, S.S. and others, 1986. Presence of luteinising hormonereleasing hormone (LHRH) in milk. Endocrinol Exp., 2 ∞C2-3), 147Ц153; Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J.Nutr., 119 (II), 1543Ц1551; Nair, R.M. and others, 1987. Studies on LHRH and physiological fluid amino acids in human colostreum and milk. Endocrinolologia Experimentalis, 21 (1), 23Ц30.

451

White, M.E. and others, 1986. Milk progesterone concentrations following simultaneous administration of buserelin and cloprostenol in cattle with normal corporal lutea. Canadian Journal of Veterinary Research, 50 (2), 285Ц286; Dinsmore, R.P. and others, 1989. Effect of gonadotropin-releasing hormone on clinical response and fertility in cows with cystyic ovaries, as related to milk progesterone concentration and days after partarition. Journal of the American Veterinary Medical Association, 195 (3), 327Ц330.

452

Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides in human milk. Am. J. Clin. Nutr., 51 (6), 985Ц990.

453

Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides inhuman milk. Am. J. Clin. Nutr., 51 (6), 985Ц990.

454

Flood, J.F. and others, 1991. Increased food intake by neuropeptide Y is due to an increased motivation to eat. Peptides, 12 (6), 1329Ц1332.

455

Amarant, T. and others, 1982. Luteinising hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk. European Journal of Biochemistry, 127 (3), 647Ц650; Baram, T and others, 1977. Gonadotropin-releasing hormone in milk. Science, 198 (4314), 300Ц302.

456

Koike, K. and others, 1997. The pituitary folliculo-stellate cell line TtT/GF augments basal and TRH-inducedprolactin secretion by GH3 cells. Life Sci, 61 (25), 2491Ц2497; Tyson, J.E. and others, 1975. The influence of prolactine secretion on human lactation. J. Clin. Endocrinol Metab, 40 (5), 764Ц773.

457

Grochowska, R. and others, 1999. Stimulated growth hormone (GH) release in Friesian cattle with respect to GH genotypes. Reproduction Nutrition Development, 39 (2), 171Ц180; Bourne, R.A. and others, 1977. Serum growth hormone concentrations after growth hormone or thyroid-releasing hormone in cows. Journal of Dairy Science, 60 (10), 1629Ц1635.

458

Chomczinsky, P. and others, 1993. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line. J. Clin. Endocrinol Metab, 77 (1), 281Ц285; Reynolds, A.M., 1991. The effects of chronic exposure to supra physiological concentrations of 3,5,3-triiodo-L-thyronine (T3) on cultured GC cells. Journal of Cellular. Physiology, 149 (3), 544Ц547.

459

Tenore, A. and others, 1980. Thyroidal response to peroral TSH in suckling and weaned rats. American Journal of Physiology, 238 (5), E428-430.

460

Slebodzinski, A.B. and others, 1998. Triiodothyronine (T3), insulin and characteristics of 5'-monodiodinase (5'-MD) in mare's milk from partarition to 21 days post-partum. Reproduction Nutrition Development, 38 (3), 235Ц244.

461

Fujimoto, N. and others, 1997. Upregulation of the estrogen receptor by triiodothyronine in rat pituitary cell lines. Journal of Steroid Biochemistry and Molecular Biology, 61 (1Ц2), 79Ц85.

462

Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J. Nutr., 119 (11), 1543Ц1551; Buts, J.P., 1998. Bioactive factors in milk. (in French.) Arch Pediatr, 5 (3), 298Ц306.

463

Faulkner, A., 1998. Insulin-like growth factor concentrations in milk and plasma after growth hormone treatment. Biochemical Society Transactions, 26 (4), S386; Baldini, E. and others, 1994. In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma. Journal of Biological Regulators and Homeostatic Agents, 8 (4), 113Ц116; Scheven, B.A. and others, 1991. Effects of recombinant human insulin-like growth factor-1 and -2 (IGF) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regulation, 1 (4), 160Ц167; Hodate, K. and others, 1990, Plasma growth hormone, insuline-like growth factor-l, and milk production response to exogenous human growth hormone-releasing factor analogs in dairy cows. Endocrinologia Japonica, 37 (2), 261Ц273.

464

Koldovsky, O., 1989. Search for the role of milk borne biologically active peptides for the suckling. J. Nutr., 119 (11), 1543Ц1551; Buts, J.P., 1998. Bioactive factors in milk. (in French.) Arch Pediatr, 5 (3), 298Ц306.

465

Westrom, B.R. and others, 1987. Levels of immunoreactive insulin, neurotensin, and bombesin in porcine colostreum and milk. J. Pediatr. Gastroenterol. Nutr., 6 (3), 460Ц465; Ehman, R. and others, 1985. Bombesin, neurotensin and pro-gamma-melanotropin in immunoreactants in human milk. Regulatory Peptides, 10 (2Ц3), 99-105.

466

Shutt, D.A. and others, 1985. Comparison of total and free cortisol in bovine serum and milk colostreum. J. Dairy Set, 68 (7), 1832Ц1834.

467

Vaarala, O. and others, 1998. Cow milk feeding induces antibodies to insulin in children Ц a link: between cow milk and insulin-dependent diabetes mellitus? Scandinavian Journal of Immunology 47 (2), 131Ц135; Slebodzinsky, A.B. and others, 1998. Triiodothyronine (T3), insulin and characteristics of 5'-monodiodinase (5'-MD) in mare's milk from partarition to 21 days post-partum. Reprod Nutr Dev, 38 (3), 235Ц244; Westrom, B.R. and others, 1987. Levels of immunoreactive insulin, neurotensin, and bombesin in porcine colostreum and milk. J. Pediatr Gastroenterol Nutr., 6 (3), 460Ц465.

468

Ferrando, T. and others, 1990. Beta-endorphin-like and alpha-MSH-like immunoreactivities in human milk. Life Sci, 47 (7), 633Ц635.

469

http://www.13.waisays.com/cancer2.htm; Newcomb, P.A. and Egan, K.M., 2006. Dairy food and ovarian cancer risk. The Lancet, March 2006, 797Ц799; Stang, A. and others, 2006. Adolescent milk fat and galactose consumption and testicular germ cell cancer. Cancer Epidemiology and Biomarkers Prevention, 15, 2189Ц2195.

470

Maruuchi, T. and others, 1998. Effects of gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo. Japanese Journal of Cancer Research, 89 (9), 977Ц983; Kuroda, H. and others, 1998. Human chorionic gonadotrophin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of IGF-1 by hCG. Int J. Cancer, 76 (4), 571Ц578; Kurbacher, C.M. and others, 1995. Influence of luteinising hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro. Tumour Biology, 16 (6), 374Ц384; Manetta, A. and others, 1995. Inhibition of growth of human ovarian cancer in nude mice by luteinising hormone-releasing hormone antagonist Cetrorelix (SB-75). Fertility and Sterility, 63 (2), 282Ц287.

471

Reiter, E. and others, 1999. Effects of pituitary hormones on the prostate. Prostate, 38 (2), 159Ц165; Lamharzi, N. and others, 1998. Luteinising hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGFЦ 2 in tumors. Regulatory Peptides, 77 (113), 185Ц192; Jungwirth, A. and others, 1997. Luteinising hormone-releasing hormone (LH-RH) antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-2 inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate, 32 (3), 164Ц172; Maezawa, H. and others, 1997. Potentiating effect of buserelin acetate, an LHRH agonist on the proliferation of ventral prostatic epithelial cells in testosterone-treated castrated rats. Int J. Urol, 4 (4), 411Ц416; Using, A.W. and others, 1993. Serological precursors of cancer serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev, 2 (1), 27Ц32; Garde, S. and others, 1993. Effect of prostatic inhibiting peptide on prostate cancer cell growth in vitro and in vivo. Prostate, 7 (2), 183Ц194.

472

Bosland, M.C., 1996. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Progress in Clinical and Biological Research, 394, 309Ц352.

473

Chapman, S. and others, 1992. Changes in adult cigarette consumption per head in 128 countries, 1986Ц1990. Tobacco Control, 1, 281Ц284.

474

http://www.who.int

475

Chapman, S. and others, 1992. Changes in adult cigarette consumption per head in 128 countries, 1986Ц1990. Tobacco Control, 1. 281Ц284.

476

http://www.who.int

477

http://www.13.waisays.com/cancer2.htm

478

Underwood, L.E., D'Ercole, J.A. and Van Wyk, J.J., 1980. Somatomedin-C and the assessment of growth. Ped. Clin. N Amer, 27, 4, 771Ц782, and Perdue, J.F. 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J. Biochem Cell Bio, 62, 1237Ц1245.

479

http://www.com/healthnews/milk.html

480

Pollack, Michael, 2003. Cancer, aging and IGF physiology. Meeting of the Royal Society of Medicine in London in October 2003, entitled ЂBiology of IGF-I: its interaction with insulin in health and malignant statesї.

481

Lonning, Per Eystein, 2003. IGF-I and breast cancer. Meeting of the Royal Society of Medicine in London in October 2003, entitled ЂBiology of IGF-I: its interaction with insulin in health and malignant statesї.

482

Yee, Doug, 2003. Targeting the IGF system for anti-tumour therapy. Meeting of the Royal Society of Medicine in London in October 2003, entitled ЂBiology of IGF-I: its interaction with insulin in health and malignant statesї.

483

Pollack, Michael, 2003. Cancer, aging and IGF physiology. Meeting of the Royal Society of Medicine in London in October 2003, entitled ЂBiology of IGF-I; its interaction with insulin in health and malignant statesї.

484

Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet, 351, 9113, 9 May, 1373Ц1375.

485

Chan, J.M., Stampfer, M.J., Giovannucci, E. and others, 1998. Plasma insulin-like growth factor-I and prostate cancer risk; a prospective study. Science, 279, 563Ц566; Harman, S.M., Metter, E.J., Blackmail, M.R., Landis, P.K. and Carter, H.B., 2000. Serum levels of insulin-type growth factor 1 (IGF-I), IGF II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J. Clin. Endocrinol Metab., 85, 4258Ц4265; Stattin, P. and nine others, 2000. Plasma insulin-like growth factor-I insulin-like growth-binding proteins, and prostate cancer risk: a prospective study. J. Natl. Cancer Inst., 92, 1910Ц1917; Chokkalingam, A.P, and 12 others, 2001. Insulinlike growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev., 10, 421Ц427; Chan, J.M., Stampfer, M.J., Ma, J. and others, 2002. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J. Natl Cancer Inst, 94, 1099Ц1106; Mantzoros, C.S., Tzonou, A., Signorello, L.B. and others, 1997. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. British Journal of Cancer, 76, 1115Ц1118; Wolk, A., Mantzoros, C.S., Andersson, S.O. and others, 1998. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. Natl Cancer Inst, 90, 911Ц915; Holly, J.M.P., Gunnell, D.J. and Davey Smith., G, 1999. Growth hormone, IGF-1 and cancer. Less intervention. Less intervention to avoid cancer? More intervention to prevent cancer. J. Endocrinol, 162, 321Ц330.

486

Yu, H. and others, 1999. Plasma levels of IGF-I and lung cancer risk, Journal of the National Cancer Institute, 91, 151Ц156.

487

Ma, J. and others, 2001. Milk intake, circulating levels of IGF-1 and risk of colorectal cancer in men. Journal of the National Cancer Institute, 93 (17), 1330Ц1336.

488

LeRoith, D. and others, 1995. The role of the IGF-I receptor in cancer. Annals of the New York Academy of Sciences, 766, 402Ц408; Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

489

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

490

Bradford Hill, A., 1965. The environment and disease; association or causation? Proceedings of the Royal Society of Medicine, 58, 295Ц300.

491

Holly, J.M.P., Gunnell, D.J. and Davey Smith, G., 1999. Growth hormone, IGF-I and cancer. Less intervention. Less intervention to avoid cancer? More intervention to prevent cancer. J. Endocrinol, 162, 321Ц330.

492

Bobbins, John, 1987. A Diet for a New America, Stillpoint Publishing.

493

www.dhn.csiro-au/crctissue.html

494

Xian, C., 1995. Degradation of IGF-I in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein. Journal of Endocrinology, 146, 2, 1 August, 215; Thornburg, W. and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology, 246, G80-G85.

495

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health Ц Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/outl9_en.html

496

Allen, N.K, and others, 2000, Hormones and Diet; Low Insulin-like Growth Factor-1 but Normal Bioavailable Androgens in Vegan Men. Brit. J. Canc., 83 (1), 95Ц97.

497

Steinman, G., 2006. Can the chance of having twins be modified by diet? The Lancet, 367 (9521), 1461Ц1462.

498

Norat and others, 2007. Diet, serum IGF-1 and IGF-BP3 in European women. European Journal of Clinical Nutrition, 61, 91Ц98.

499

The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating to Public Health Ц Outcome of discussions. http://europa.eu.int/comm/dg24/health/sc/scv/out19_en.html

500

Heaney, R.P. and others, 1999. Dietary changes favourably affect bone remodelling in older adults, Journal of the American Dietetic Association, 99 (10), 1228Ц1233.

501

Gunnell, D.L. and 10 others, 2003. Are diet Ц prostate-cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. British Journal of Cancer, 88, 1682Ц1686.

502

World Cancer Research Fund, 1997. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute of Cancer Research.

503

Allen, N.E., Appleby, P.N., Davey, G. K. and Key, T.J., 2000. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br. J. Cancer. 83, 95Ц97.

504

Yaker, S. and others, 2005. The role of the growth hormone/ IGF axis in tumour growth and progression: lessons from animal models. Cytokine and Growth Factor Reviews, 16 (4Ц5), 407Ц420; Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

505

Mannisto, S. and others, 1999. Diet and the risk of breast cancer in a case control study: does the threat of disease have an influence on recall bias? Journal of Clinical Epidemiology, 52 (5), 429Ц439; Outwater, J.L. and others, 1997. Dairy products and breast cancer: the IGF-1, estrogen and bGH hypothesis. Medical Hypotheses, 48 (6), 453Ц461; Gaard, M. and others, 1995. Dietary fat and the risk of breast cancer: a prospective study of 25 892 Norwegian women. Int J. Cancer, 63 (1), 13Ц17; Decarli, A. and others, 1986, Environmental factors and cancer mortality in Italy: correlational exercise. Oncology, 43 (2), 116Ц126; Rose, D.P. and others, 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58 (11), 2363Ц2371; Shimada, A. and others, Ecological approach to the eating habits and the cancer mortality of Brazilian people. (in het Japans) Can No Rinsho, 32 (6), 631Ц640; La Vecchia, C. and others, 1986, Age at first birth, dietary practises and breast cancer mortality in various Italian regions. Oncology, 43 (1), 1Ц6; Talamini, R. and others, 1984. Social factors, diet and breast cancer in a northern Italian population. Br. J. Cancer. 49 (6), 723Ц729.

506

Rose, D. P. and others, 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58 (11), 2363Ц2371.

507

Schuurman, A.G. and others, 1999, Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study, Br. J. Cancer, 80 (7), 1107Ц1113; Giovannucci, E., 1999. Nutritional factors in human cancers. Advances in Experimental Medicine and Biology, 472, 29Ц42; Giovanucci, E., 1998. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes and Control, 9 (6), 567Ц582; Willet, W.C., 1997. Nutrition and Cancer. Salud Publica de Mexico, 39 (4), 298Ц309; De Stefani, E. and others, 1995, Tobacco, alcohol, diet and risk of prostate cancer. Tumori, 81 (5), 315Ц320; Le Marchand, L. and others, 1994. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology, 5 (3), 276Ц282; Talamini, R. and others, 1992. Diet and prostate cancer: a case control study in northern Italy. Nutrition and Cancer, 18 (3), 277Ц286; La Vecchia, C. and others, 1991. Dairy products and the risk of prostatic cancer. Oncology, 48 (5), 406Ц410; Mettlin, C. and others, 1989. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case control study. Cancer, 64 (3), 605Ц612; Snowdon, D.A., 1988. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists. Am. J. Clin. Nutr., 48 (3 Suppl), 739Ц748; Talamini, R. and others, 1986. Nutrition, social factors, and prostate cancer in a northern Italian population. Br. J. Cancer, 53 (6), 817Ц821; Rose, D.P. and others, 1986. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58 (11), 2263Ц2271.

508

Newby, J.A. and Howard, 2006. Environmental influences in cancer aetiology, 2006, 1-59.

509

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

510

Ѕ‘– (BGH, Bovine Growth Hormone) Ц бычий фактор (гормон) роста. Ц ѕримеч. ред.

511

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

512

Lawrence R., 1994. Breastfeeding Ц A Guide to the Medical Profession, Fourth edition. Mossby.

513

Holly, J.M.P., Gunnell, D.J. and Davey Smith, G., 1999. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol, 162, 321Ц330.

514

Giudice, L.A., 1992. Insulin-like growth factors and ovarian follicular development. Endocrine Reviews, 13, 641Ц669.

515

Westlev, B.R. and May, F.E.B., 1994. Role of insulin-like growth factors in steroid modulated proliferation. Journal of Steroid Bioehemistry and Molecular Biology, 51, 1Ц9; Marcelli, M., Haidacher, S.J., Plymate, S.R. and Birnbaum, R.S., 1995. Altered growth and insulin-like growth factor-binding protein-3 production in PC-3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology, 136, 1040Ц1048.

516

Holly, J.M.P., Gunnell, D.J. and Davey Smith, G., 1999. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol, 162, 321Ц330.

517

Bernstein, I. and Ross, R.K., 1993. Endogenous hormones and breast cancer risk. Epidemiol Res, 15, 48Ц65; Pike, M.C. and others, 1993. Estrogens, progestogens, normal breast proliferation and breast cancer risk. Epidemiol Reviews, 15, 17Ц35.

518

Bocchinfuso, W.F. and others, 2000. Induction of mammary gland development in estrogen receptor-alpha knoclout mice. Endocrinology; 141; 2983Ц2994; Attwood, C.S. and others, 2000. Progesterone induces side-branching of the ductal epithelium in the mammary glands of prepubertalmice. J. Endocrinology, 167, 39Ц52.

519

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Healths. Benbella Books.

520

www.breakthrough.org.uk

521

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

522

Cramer, D.W. and others, 1989. Galactose consumption and metabolism in relation to the risk of ovarian cancer Lancet, 2, 66Ц71.

523

Fairfield and others, 2004. A prospective study of dietary lactose and ovarian cancer. Int J. of Cancer, 110 (2), 271Ц277.

524

Larsson, S.C. and others, 2004. Milk and lactose intakes and ovarian cancer risk. In the Swedish Mammography Cohort. Amer J. Clinical Nutrition, 80 (5), 1353Ц1357.

525

Larsson, S.C. and others, 2005. Milk, milk products and lactose intake and ovarian cancer risk: a meta analysis of epidemiological studies. Int J. of Cancer.

526

Ganmaa, D. and Sato, A., 2005. Possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses, 65 (6), 1028Ц1037.

527

Hartman, S. and others, 1998. Natural occurrence of steroid hormones in food. Food Chemistry, 62, 7-20; Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

528

Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.

529

Bahna, S,L., 1987. Milk allergy in infancy. Ann Allergy. 59, 131.

530

Dunea, G., 1982. Beyond the Etheric. BMJ, 285, 428Ц429.

531

Kretchmer, N., 1981. The Significance of lactose intolerance. In: Paige, D.M. and Bayless, T.M., Editors., Lactose Digestion: Clinical and nutritional implications. Johns Hopkins University Press.

532

http://www.fda.gov/fdac/features/2001/4 01_food.html

533

http://www.ifst.org/hottop19.htm

534

Taylor, S.L., 1992. Chemistry and detection of food allergens. Food Technology, 46 (5), 146Ц152.

535

Saarinen, K.N. and others, 2005. Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. Journal of Allergy and Clinical immunology, 136 (4), 869Ц875.

536

http://www.ifst.org/hottop19.htm

537

Martin, Peter, 2002. Milk: Nectar or poison? Sunday Times Magazine, July 21. 2002.

538

Thorsdottir, I. and Ramel, A., 2003. Dietary intake of 10Ц to 16-year-old children and adolescents in Central and Northern Europe and association with the incidence of type-1 diabetes. Annals of Nutrition and Metabolism, 47 (6), 267Ц275.

539

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

540

TB bacteria found in treated milk. Sunday Times, 20 February, 2000.

541

Bull, T.J. and others, 2003. Detection and verification of Mycobactenum avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease, Journal of Clinical Microbiology. 41 (7), 2915Ц2923.

542

Millar, D. and others, 1996. IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Applied and Environmental Microbiology, 62 (9), 3446Ц3452.

543

Pickup, R.W. and others, 2005. MAP in the catchment area and water of the River Taff in South Wales, UK and its potential relationship to clustering of Crohn's disease cases in the city of Cardiff. Applied and Environmental Microbiology, 71 (4), 2130Ц2139.

544

FSA/SE, 2001. Task force on E.coli 0157. www.food.gov.uk/mnltimedia/pdfs/ecolitaskfinreport.pdf

545

ƒжон  ребс Ц эколог и профессор ќксфордского университета, председатель совета  омитета по пищевым стандартам ¬еликобритании. Ц ѕримеч. ред.

546

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

547

Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. London: Virgin Books.

548

Robbins, John, 1987. A Diet for a New America. Stillpoint Publishing.

549

Hegsted D.M., 1986. Calcium and osteoporosis. J. Nutr., 116, 2316Ц2319.

550

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

551

јкне Ц угрева€ сыпь. Ц ѕримеч. ред.

552

Ademamowo, C.A. and others, 2005. High-school dietary dairy intake and teenage acne. Journal of the American Academy of Dermatology, 52 (2), 207Ц214.

553

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

554

Toohey, M.L., and others, 1998. Cardiovascular disease risk factors are lower in African-American vegans compared to lacto-ovo-vegetarians. Journal of the American College of Nutrition, 17 (5), 425Ц434.

555

Park, M. and others, 2005. Consumption of milk and calcium in mid-life and the future risk of Parkinson disease. Neurology, 64, 1047Ц1051.

556

World Cancer Research Fund and American Institute for Cancer Research. 1997. Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington DC: American Institute for Cancer Research (http://www.aicr.org/report2.htm).

557

http://www.pcrm.org/health/Dairy_and_Prostate_Cancer/d_p_article.html

558

Plant, Jane and Tidey, Gill, 2002. The Plant Programme. Paperback edition. Virgin Books; Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteporosis. Virgin Books; Plant, Jane, 2004, updated 2007. Prostate Cancer: Understand, Prevent and Overcome. Virgin Books; Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books.

559

Smith-Warner, S.A. and Giovannucci, E., 1999. Fruit and vegetable intake and cancer. In: Heber, D., Blackburn, G.L. and Go, V.L.W., editors. Nutritional oncology. San Diego: Academic Press. 153Ц183.

560

American Institute for Cancer Research, 2000. Press Release (August 31, 2000) from the AICR Annual Research Conference 2000: New Methods in Clinical Trials Lending New Insights on Diet-cancer Connection, Expert Says.

561

National Cattlemen's Beef Association, 1999. Conjugated Linoleic Acid and Dietary Beef. An Update. Beef Facts: Nutrition, Series No. FS/N 016.

562

Ip, C., Scimeca, J.A., and Thompson, H.J., 1994. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer, 74, 1050Ц1054.

563

Steinhart, Carol, 1996. Conjugated Linoleic Acid: The Good News about Animal Fat. Journal of Chemical Education, 73, A302. http://jchemed.chem.wisc.edu/Journal/Issues/1996/Dec/absA302.html

564

Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China, American Journal of Clinical Nutrition, 59 (Suppl.), 11 535-11 615.

565

Bernstein, L. and Ross, R.K., 1993. Endogenous hormones and breast cancer risk. Epidemiol Reviews, IS, 48Ц65; Pike and others, 1993. Estrogens, progestogens, normal breast proliferation and breast cancer risk. Epidemiol reviews. 15, 17Ц35.

566

Prentice. R. and others, 1990. Dietary fat reduction and plasma oestrodial concentration in healthy postmenopausal women. J. Natl Cancer Inst, 82, 129Ц134.

567

www.mdanderson.org/departments/nutririon/display.cfm/id=51f759d8-98b2-lld5''813300508b603al4&method=displayfull&pn=51f7589e-98b2-lld5-813300508b603al4

568

Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.

569

Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

570

Ornish, D and others, 2005. Intensive lifestyle changes may affect the progression of prostate cancer. Journal of Urology, 174 (3), 1065Ц1069.

571

Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.

572

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

573

Plant, Jane and Tidey, Gill, 2005. Eating for Better Health. Virgin Books. See also, Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Longterm Health. Benbella Books; Robbins, John, 1987. A Diet for a New America . Stillpoint Publishing.

574

Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine, 2006, 1Ц59.

575

Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59 (Suppl.), 11 535-31 615.

576

Food Chemical News, April 29, 1996.

577

Kurzer, M.S. and Xu, X., 1999. Dietary Phytoestrogens. Annual Reviews of Nutrition, 17, 353Ц381.

578

Adlercreutz, H, 1995. Phyto-oestrogens: Epidemiology and a Possible Role in Cancer Protection. Environmental Health Perspectives, 103 (Suppl. 7), 103Ц112; Adlercreutz, H., Mazur, W., Bartels, P., Elomaa, V.-V., Watanabe, S., Wahala, K., Landstrom, M., Lundin, E., Bergh, A., Damber, J.-E., Aman, P., Widmark, A., Johansson, A., Zhang, J.-X. and Hallmans, G., 2000. Phytooestrogens and Prostate Disease. J. Nutr., 130, 658S-659S.

579

http://www.ifst.org/hottop34.htm

580

Adlercreutz, H., Mazur, W., Bartels, P., Elomaa, V.-V., Watanabe, S., Wahala, K., Landstrom, M., Lundin, E., Bergh, A., Damber, J.-E., Aman, P., Widmark, A., Johansson, A., Zhang, J.-X. and Hallmans, G., 2000. Phyto-oestrogens and Prostate Disease. J. Nutr., 130, 658S-659S.

581

Zhou, J.-R., Gugger, E.T., Tanaka, T., Guo, Y., Blackburn, G.L. and Clinton, S.K., 1999. Soy-bean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr., 129, 1628Ц1635; Davis, J.N., Singh, B., Bhuiyan, M. and Sarkar, F.H., 1998, Genistein-induced upregulation of p21WAFl, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer, 32, 123Ц131; The Royal Society, 2000. Endocrine-disrupting chemicals. Document 06/00. The Royal Society; Setchell, K.D.R., 1998. Phyto-oestrogens: the biochemistry, physiology and implications for human health of soy isoflavones, Nutrition, 68, 1333S-1346S.

582

Glenville, Marilyn, 2003. The New Natural Alternatives to HRT. Second edition. Kyle Cathie.

583

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

584

Glenville, Marilen, 2003. The New Natural Alternatives to HRT. Second edition. Kyle Cathie.

585

Robbins, John, 1987. A Diet for a New America . Stillpoint Publishing; Kradjian, R.M., 1994. Save Yourself from Breast Cancer. New York: Berkley Books; McDougall, John, 2000. The McDougall Program for Women; Lee, John R., 1999. Natural Progesterone. Second revised edition. Jon Carpenter; Plant, Jane and Tidey; Gill, 2003. Understanding, preventing and overcoming osteoporosis. Virgin Books; Fox, Douglas, 2001. Hard cheese. New Scientist, 15 December 2001, 42Ц45.

586

http://wayne.unl.edu/00aprilcolumn.htm

587

Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, July 21, 2002. 46Ц54.

588

Website of the American Cancer Society, http://www.cancer.org/docroot/eto/content/eto_5_3x_soy-bean.asp?siteare a=&viewmode=print

589

Gottlieb, Scott, 2003. Men should eat nine servings of fruit and vegetables a day. BMJ, 326, 1003.

590

UK Ministry of Agriculture, Fisheries and Food advice as reported in the Sunday Times, 1999.

591

Willet, W.C., 1994. Micronutrients and cancer risk. Am J. Clin. Nutr., 59, (suppl), 1162S-5S. See also: Willett, Walter C., Colditz, Graham A. and Mueller, Nancy A., 1996. Strategies for Minimising Cancer Risk. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 88Ц95.

592

Huang, M.-T., Asawa T., Ho C.-T., Rosen R.T., eds, 1994. Food phytochemicals for cancer prevention I Ц fruits and vegetables. Washington, DC: American Chemical Society; Ho, C.-T., Osawa, T., Huang, M.-T. and Rosen, R.T., eds, 1994. Food phytochemicals for cancer prevention II Ц teas, spices, herbs. Washing ton, DC: American Chemical Society; American Institute for Cancer Research, ed., 1996. Dietary phytochemicals in cancer prevention and treatment. New York: Plenum Press; Liu, R.H. and Espinosa, A., 2000. Bio-active Compounds from Fruits and Vegetables in the Prevention of Cancer. In: Agriculture in the New Century: Managing Bio-Resources and Bio-Diversity, National Taiwan University, Taipei, Taiwan, 53Ц59.

593

Greenwald, Peter, 2002. Cancer chemoprevention. BMJ, 324, 714Ц718.

594

Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group, Heinonen, O.P., Huttunen, J.K. and Albanes, D., 1994. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J. Mod, 330, 1029Ц1035; Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R. and Class, A., 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J. Med, 334, 1150Ц1355.

595

Ursell, Amanda, 2007. Eat a rainbow to stay healthy. The Times (T2), 6 February, 2007.

596

Gunnell, D L and 10 others, 2003. Are diet Ц prostate-cancer association mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBPЦ 3 in healthy middle-aged men. British Journal of Cancer, 88; 1682Ц1686.

597

Mucci, L.A. and six others, 2001. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system. BJU Int. 87, 814Ц820.

598

http://www.flax.com.fda

599

http://info.cancerresearchuk.org/healthyliving/dietandhealthyeating/theepicstudy

600

Am. J. Epidemiol, 1994. 139 (11), s 37.

601

Inside Story. Which? April 2002, 4.

602

Lu, C. and others, 2006. Organic diets significantly lower children's dietary exposure to organophosphorus pesticides. Environmental Health Perspectives, 114 (2), 260Ц263.

603

Doll, R. and Peto, R., 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. New York: Oxford University Press.

604

Boseley, Sarah, 2006. Expert revered for painstaking work that proved link between smoking and cancer. Guardian, 8 December, 2006.

605

Colborn, T.T., 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives, 101 (5), 378Ц384.

606

McKinlay, R. and others, in press. Endocrine-disrupting pesticides: implications for risk assessment.

607

Royal Commission on Environmental Pollution, 2005. Special report, crop spraying and health of residents and bystanders.

608

Mittelstaedt, Martin, 2002. Data point to breast-cancer risk. Globe and Mail, 22 November 2002, A5.

609

McMichael, A.J., 1993. Planetary Overload Ц Global Environmental Change and the Health of the Species. Cambridge University Press.

610

Royal Commission on Environmental Pollution, 2002. A Short Report on the Environmental Effects of Civil Aircraft in Flight. Royal Commission on Environmental Pollution.

611

Bristow, Amanda, 2002. Which?, April 2002, 22Ц23.

612

Campbell, T Colin, Campbell, Thomas M. II, 2006. The China Study. Benbella Books; McDougall, J. and others, 1995. Rapid reduction of serum cholesterol and blood pressure by a twelve-day, very low fat, strictly vegetarian diet. J. Am. Coll Nutr., 14, 491Ц496.

613

ICON. September 2002.

614

http://www.eurocbc.org/page641.html http://www.ciwf.co.uk/Trust/FF/farm_facts_fish_farming.htm

615

Cho, E. and others, 2006. Red meat intake and risk of breast cancer among premenopausal women. Archives of International Medicine, 166, 2253Ц2259.

616

http://info.cancerresearchuk.org/healthyliving/dietandhealthyeating/theepicstudy

617

JAMA, 1985, 254 (3), 356Ц357.

618

http://www.prostatepointers.org/cmyers/pf0696.html

619

http://info.cancerresearchuk.org/healthyliving/dietandhealthycating/theepicstudy

620

J. Nat Cancer Inst, 1994, 86 (18), 1409Ц1415.

621

Am. J. Epidem, 1994, 139 (11), S37.

622

http://www.prostatepointers.org/cmyers/pf0696.html; American Heart Association Cookbook, fifth edition, 1995. New York: Times Books, Random House; Pritikin, Nathan, 1979. The Pritikin Program for Diet and Exercise. New York: Bantam Books; Ornish, D., 1990. Dr Dean Ornish's Program for Reversing Heart Disease. New York: Ballantyne Books.

623

Van de Weyer, Courtney, 2005. Changing diets, changing minds. Sustain.

624

www.annieappleseedproject.org/nutgenprotin.html

625

Van de Wever, Courtnev, 2005. Changing diets, changing minds. Sustain.

626

Trichopoulos, Dimitrios, Li, Frederick P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80Ц85.

627

Djamgoz, M.B.A. and Isbilen, B., 2006. Dietary compounds as anti-cancer agents: a preliminary evaluation of ion channels and membrane excitability as possible target mechanisms. The Lancet.

628

http://www.findarticles.com/cf_0/m0FKA/5_62/62702338/pl/article.jhtmi?term=turmeric%2C+Liz+Brown

629

Steinmetz, K.A. and Potter, J.D., 1991. Vegetables, fruity and cancer, II. Mechanisms. Cancer Causes Control, 1, 427Ц442; Lam, L.K.T., Zhang, J., Hasegawa, S. and others, 1994. Inhibition of chemically induced carcinogenesis by citrus liminoids. In: Huang, M-T., Asawa, T., Ho, C-T. and Rosen, R.T., eds. Food phytochemicals for cancer prevention, I Ц fruits and vegetables. Washington, DC: American Chemical Society, pp, 209Ц219; Zheng, C.Q., Zhang, J., Kenney, P.M. and Lam, L.K.T., 1994 Stimulation of glutathione S-transfcrase and inhibition of carcinogenesis in mice by celery seed oil constituents. In: Huang, M.-T., Asawa, T., Ho, C.-T. and Rosen, R.T., eds, Food phytochemicals for cancer prevention. I Ц fruits and vegetables. Washington, DC: American Chemical Society, pp. 230Ц238.

630

Nakatani, N, 1994. Chemistrv of antioxidants from Labiatae herbs. In: Ho, C.-T., Osawa, T., Huang, M.-T. and Rosen, R.T., eds. Food phytochemicals for cancer prevention, II Ц teas, spices, herbs. Washington, DC: American Chemical Society, pp. 144Ц153.

631

Ho, C.-T., Ferraro, T., Chen, Q and others; 1994. Phytochemicals in teas and rosemary and their cancer-preventive properties. In: Ho, C.-T., Osawa, T., Huang, M.-T. and Rosen, R.T., eds. Food phytochemicals for cancer prevention, II Ц teas, spices, herbs. Washington, DC: American Chemical Society, pp. 2-19.

632

Kikuzaki, H. and Nakatani, N, 1993. Antioxidant effects of some ginger constituents. Journal of Food Science, 58, 1407Ц1410.

633

Zheng, G.Q., Kenney, P.M. and Lam, L.K.T., 1993. Potential anticarcinogenic natural products isolated from lemongrass oil and galanga root oil. Journal of Agricultural and Food Chemistry, 41, 153Ц156; Zheng, G.Q., Kenney, P.M. and Lam, L.K.T., 1992. Anethofuran, carvone, and limonene: potential cancer chemopreventive agents from dill weed oil and caraway oil. Planta Medico, 58, 338Ц341; Zheng, G.Q., Kenney, P.M., Zhang, J. and others, 1993. Chemoprevention of benzo[a]pyrene-induced forestomach cancer in mice by natural phthalides from celery seed oil. Nutr. Cancer, 19, 77Ц86; Zheng, G.Q., Kenney, P.M. and Lam, L.K.T., 1992. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. Journal of Natural Products, 55, 999-1003; Zheng, C.Q, Kenney, P.M. And Lam, L.K.T., 1992. Myristicin: a potential cancer chernopreventive agent from parsley leaf oil. J. Agric. Food Chem., 40, 107Ц110.

634

http://www.pcrm.org/health/Dairy_and_Prostate_Cancer/d_p_article.html; World Cancer Research Fund and American Institute for Cancer Research. 1997. Food, Nutrition and the Prevention of Cancer: a global perspective. Washington DC: American Institute for Cancer Research, (http://www.aicr.org/report2.htm)

635

Journal of the American Diabetic Association, May 2001; http://www.wad-sworth.corn/nutrition_d/special_features/news/nutu1201.html.

636

Thompson, L.U., 1994. Antioxidants and hormone-mediated health benefi ts of whole grains. Critical Reviews in Food Science and Nutrition, 34, 473Ц497.

637

Thompson, L.U., 1992. Potential health benefi ts of whole grains and their components. Contemp Nutr., 17 (6), 1Ц2.

638

Elson, C.E. and Yu, S.G., 1994. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J. Nutr., 124, 607Ц614.

639

Elson, C.E. and Yu, S.G., 1994. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J. Nutr., 124, 607Ц614.

640

Fox, Douglas, 2002. Bread to blame for plague of pimples. New Scientist, 7, December 2002.

641

http://www.dorway.com/badnews.html

642

http://www.stevia.net; http://www.holisticmed.com/sweet/

643

Pesticide residues found in Indian bottled water. 2003. BMJ, 326, 352.

644

http://www.annieappleseedproject.org/nutgenprotin.html, reporting on a conference on nutritional genomics and proteomics in cancer prevention in September 2002, at the USNIH, Bethesda.

645

Why tea is not so good for you after all. The Times, 9 January 2007.

646

www.diagnose-me.com

647

http://rescarch.kib.ki.se/e-uven/public/51419.html

648

ENDS Report.

649

http://www.vegansociety.com/html/info/info28.html

650

http://www.vegansociety.com

651

Royal College of Physicians, 2002. Nutrition and patients: a doctor's responsibility,

652

http://www.pcrm.org/health/Dairy_and_Prostate_Cancer/d_p_article.html

653

Berger, Abi, 2002. Science commentary: What does zinc do? BMJ, 325, 1062Ц1063.

654

Hambridge, K. M., Casey, C. E. and Krebs, N. F., 1986. Zinc, In: Trace Elements in Human and Animal Nutrition, Fifth Edition, Mertz, W., Ed. Academic Press, Inc. London.

655

Medical Report: Prostate Cancer. ICON, 2002, 1 (5), 8-10.

656

McCusker. R.H., 1998. Controlling Insulin-Like Growth Factor Activity and the Modulation of Insulin-Like Growth Factor Binding Protein and Receptor Binding. J. Dairy Sci., 81, 1790Ц1800.

657

Josefson, Deborah, 2002. Popping a multivitamin daily can keep disease at bay. BMJ, 324, 1544.

658

Van de Weyer, C., 2005. Changing diets, changing minds. Sustain.

659

Van de Weyer, C., 2005. Changing diets, changing minds. Sustain.

660

The Lancet, 1976, 880Ц881.

661

Johnson, C., 1999, Environmental controls in iodine deficiency disorders (IDD), Earthworks, 9 November, p. 3, British Geological Survey.

662

Greenwald, Peter, 1996. Chemoprevention of cancer. Scientific American, September 1996, 96Ц99.

663

Olivotto, Ivo, Hotter, Abram and Lesperance, Mary, 2002. In Breast Cancer Research and Treatment, http://www.nlm.nih.gov/medlineplus/news/fullstory_10706.html

664

Bender, David A., 2002. Dally doses of multivitamin tablets. BMJ, 325, 173Ц174.

665

Annals of Internal Medicine, July 1, 2003; http://www.nlm.nih.gov/medlineplus/news/fullstory_13210.html

666

Kmietowicz, Zosia, 2003. Food watchdog warns against high doses of vitamins and minerals. BMJ, 326, 1001.

667

http://www.nlm.nih.gov/medlineplus/news/fullstory_13219.html

668

Gluud, C., 2007. Journal of the American Medical Association, 297, 842; see also Can vitamin supplements do more harm than good? New Scientist, v28, February 2007, 6.

669

Oakley, Godfrey P., 2002. Delaying folic acid fortification of flour. BMJ, 324, 1348Ц1349.

670

Reynolds, Edward, 2002. Fortification of flour with folic acid. BMJ, 324, 918.

671

Feldman, David, 2002. Pathways of Vitamin D Action to Inhibit Prostate Cancer Cell Growth, www.annieappleseedproject.org/nutgenprotin.html

672

Campbell, T.C, and Campbell, T.M., 2006. The China Study. Benbella Books.

673

http://bioscience.igh.cnrs.fr/2001/v6/d/hansen/2.asp

674

Seol, J.G. and fi ve others, 1998. Telomerase activity in acme myelogenous leukemia: clinical and biological implications. Br. J. Haematology, 100, 156Ц165; Savoysky, E. and seven others, 1996, Down-regulation of telomerase activity is an early event in the differentiation in HL-60 cells. Biochem. Biophys. Res. Commun., 226, 329Ц334; Albanell, J. and fi ve others, 1996. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res., 56, 1503Ц1508.

675

Campbell. T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

676

Barretto, A.M., Schwartz, G.G., Woofruff, R. and Cramer, S.C., 2000. 5-hydroxyvitamin D-3, the prohormone of 1,25-dihydroxyvitamin D-3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiology Biomarkers & Prevention, 9, 3, 265Ц270.

677

http://www.rense.com/gencral/dair.htm

678

Spallholz, J.E., Stewart, J.R., 1989. Advances in the role of minerals in immunobiology. Center for Food and Nutrition, Texas Tech University, Lubbock 79409. Biol Trace Elem Res. Mar, 19 (3) 129Ц151.

679

Gynecologic, 2004, 93, 320Ц327.

680

Redbook, April, 1989, v172, n6, p. 96 (5).

681

Niki, E., Noguchi, N, Tsuchihashi, H. and others, 1995. Interaction among vitamin C, vitamin E and beta-carotene. Am. J. Clin. Nutr., 62 (Suppl), 1322S-1326S.

682

Craig, Winston J., 2002. Phyiochemicals: Guardians of Our Health, http://www.andrews.edu/NUFS/phyto.html, 03/12/02.

683

New Scientist, August 2006.

684

—ледуйте инструкци€м изготовител€ и не превышайте рекомендуемую дозу.  ачество таблеток или жиров зависит от фирмы-производител€.

685

—ледуйте инструкци€м изготовител€ и не превышайте рекомендуемую дозу.  ачество таблеток или жиров зависит от фирмы-производител€.

686

—ледуйте инструкци€м изготовител€ и не превышайте рекомендуемую дозу.  ачество таблеток или жиров зависит от фирмы-производител€.

687

Anon. 2003. Growing problems: Endocrine disruptors under the spotlight. ENDS Report, 336, 20Ц23.

688

Vikse, R. and others, 1999. Heterocyclic amines in cooked meat. Tidsskr Nor Laegeforen, 119 (1), 45Ц49.

689

Skog, K. and others, 1997. Polar and non-polar heterocyclic amines in cooked fi sh and meat products and their corresponding pan residues. Food Chemical Toxicology, 35 (6), 555Ц565.

690

BMJ, 325, 1250.

691

JAMA, 1985, 254 (3), 356Ц357.

692

JIFSTAN/NCFST Acrylamide in Food Workshop, 1989. White paper for Working Group 5: Risk Communication. National Research Council, National Academy of Sciences (NRC-NAS). Improving Risk Communication. National Academy Press. Washington DC.

693

Fleck, Fiona, 2002. Experts launch action on staple foods. BMJ, 325, 120; Anon. 2002. Acrylamide dues found in Asparagine. ICON, 1 (6), 24.

694

US Environmental Protection Agency, http://www.epa.gov/ttn/atw/hlthef/acrylami.html

695

http://ntp-server.niehs.nih.gov/htdocs/Chem_H&S/NTP_Chem7/Radian79-06-1.html

696

http://www.nsc.org/library/chemical/Acrylami.htm

697

Anon. 1997. Acrylamide. Toxic Air Contaminant Identifi cation. List Summaries Ц ARB/SSD/SES. September 1997.

698

Advisory Committee on Hazardous Substances. Sixth Annual Report (2001Ц2002). Department for Environment, Food and Rural Affairs; The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.

699

US Environmental Protection Agency, http://www.epa.gov/ttn/atw/hlthef/acrylami.html

700

http://ntp-server.niehs.nih.gov/htdocs/Chem_H&S/NTP_Chemy/Radian79-06-1.html

701

http://www.foodstandards.gov.uk/mi3ltimedia/webpage/acrylamide_study_faq

702

www.cancerresearchuk.org

703

White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377Ц380.

704

Walsh, Kiri, King, Michael, Jones, Louise, Tookman, Adrian and Blizzard, Robert, 2002. Spiritual beliefs may affect outcome of bereavement: prospective study. BMJ, 324, 1551Ц1554.

705

White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377Ц380.

706

White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377Ц380.

707

White, Craig A. and Macleod, Una, 2002. ABC of psychological medicine: Cancer. BMJ, 325, 377Ц380.

708

Petticrew, Mark, Bell, Ruth and Hunter, Duncan, 2002. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ, 325, 1066Ц1069.

709

Graham, J, Ramirez, A, Love, S, Richards, M and Burgess, C. 2002. Stressful life experiences and risk of relapse of breast cancer: observational cohort study. BMJ, 324, 1420Ц1422.

710

Beales, D., 2004. Beyond mind-body dualism: implications for patient care. Journal of Holistic Healthcare, 1 (3).

711

Ernst, Edzard (ed.), 2001. The desktop guide to complementary and alternative medicine. Mosby.

712

King, Michael and five others, 2002. Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. BMJ, 324, 947.

713

http://www.nccn.org/patient_gls/_english/_prostate/

714

European Journal of Cancer, 2003, 39, 1562Ц1567; quoted in BMJ, 327, 402.

715

Plant, Jane and Stephenson, Janet, in preparation. Breakthrough Anxiety and Depression.

716

Bartram, Thomas, 1998. Bartram's Encyclopedia of Herbal Medicine. London: Robinson.

717

Miller, G H, 1996. Can Active or Passive Smoking Increase Breast Cancer Mortality? Cancer Detect Prevent 20 (5).

718

Mayor, Susan. 2002. Pregnancy and early smoking increases breast cancer risk. BMJ, 325, 12 October 2002, 793.

719

Cancer Epidemiology, Biomarkers and Prevention, July 2003; http://www.nlm.nih.gov/medlineplus/news/fullstory_13352.html

720

Plant, Jane and Tidey, Gill, 2003. Understanding, preventing and overcoming osteoporosis. Virgin Books.

721

Goodman-Gruen, D. and Barrett-Connor, E., 1997. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. American Journal of Epidemiology, 145, 970Ц976; Kaklamani, V.G., Linos, A., Kaklamani E., Markaki, I. and Mantzoros, C., 1999. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology, 17. 813Ц817.

722

Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.

723

The Environment Agency, March 2000. Endocrine-disrupting substances in the environment: The Environment Agency's Strategy, The Environment Agency, Bristol, UK.

724

јлармистка (от англ. alarm Ц тревога, сигнал опасности, сигнал тревоги) Ц распространительница тревожных (обычно необоснованных) слухов. Ц ѕримеч. ред.

725

Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, S, 69Ц96; Plant, J.A. and Davis, D.L., 2003. Breast and prostate cancer: sources and pathways of endocrine-disrupting chemicals (EDCs). In Geology and Health. Skinner, H.C.W. and Berger, A.R. (editors). OUP. 95Ц99.

726

McKinlay, R. and others, in press. Endocrine disrupting pesticides: implications for risk assessment.

727

Toppari, J., Larsen, J.C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L-J., Jr, Jegou, B., Jensen, T.K., Jouannet, P., Keiding, N., Leffers, H., McLachlan, J.A., Meyer, O., Muller, J., Rajpert-De Meyts, E., Scheike, T., Sharpe, R.M., Sumpter, J.S., and Skakkebaek, N.E., 1996. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives, 104, 741Ц803.

728

www.cancersupportinternational.com

729

The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24; Annual Reports of the (UK) Chemical Stakeholders Forum, 2002, and The Advisory Committee on Hazardous Substances, 2002; Miller, W.R. And Sharpe, P.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, 5, 69Ц96.

730

Charlier, C.C.J., 2002. Determination of organochlorine pesticide residues in the blood of healthy individuals. Clinical Chemistry and Laboratory Medicine, 44, 361Ц364; WWF, 2003. UK national biomonitoring survey. WWF.

731

MDuffie, H.H., 2005. Host factors and genetic susceptibility: a paradigm of the conundrum of pesticide exposure and cancer associations. Reviews on Environmental Health. 20 (2), 77-101.

732

Mathur, V., 2002. Breast cancer incidence and exposure to pesticides among women originating from Jaipur. Environment International, 28 (5), 331Ц336; Starek, A., 2003. Estrogen and organochlorine xenoestrogens and breast cancer risk. International Journal of Occupational Medicine and Environmental Health. 16 (2), 113Ц124.

733

Frigo, D.E., 2004. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis, 25 (Feb), 249Ц261; Lewis, J.S. and others, 2005. Differential effects of 16-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. Journal of Molecular Endocrinology, 34, 91-105; Tessier, D.D., 2001. Increased ErbB-2 tyrosinekinase activity, MAPK phosporylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicological Sciences. 60 (1), 38Ц43.

734

Swan S.H. and others, 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives, 113, (8).

735

Kawauchi, H., 2002. Identifi cation of growth hormone in the sea lamprey, an extant representative of a group of the most ancient vertebrates. Endocrinology, 143 (12), 4916Ц4921; Park, J.I., 2005. Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signalling system from nematodes to humans. Endocrine Journal, 26 (3), 267Ц276.

736

Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.

737

Edwards, T.T., 2006. Reproductive dysgenesis in wildlife: a comparative view. International Journal of Andrology, 29 (1), 109Ц121; Guillette, L.L., 1999. Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. General and Comparative Endocrinology, 116(3), 356Ц372.

738

Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.

739

Webb, S.F., 2000. Risk assessment approaches for Pharmaceuticals. In: International Seminar: Pharmaceuticals in the Environment, Technological Institute, Section on Environmental Technology, Brussels, 2000.

740

Kolpin, D.A., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. and Buxton, H.T.; 2002. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999Ц2000: A National Reconnaissance. Environmental Science & Technology, 36, 1202Ц1211.

741

McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html; Morelli, J., 2000. Are Our Medicines Tainting the Environment? http://webmd.lycos.com/content/article/25/1728_58159?

742

McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html

743

The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.

744

Hamburger Umwelt Institute, 1997. Poor Design Practices Ц gaseous emissions form complex products.

745

Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26Ц30 November 2000.

746

http://www.le.ac.uk/ieh

747

Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

748

The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt.

749

Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59.

750

Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

751

Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 11 (4), 389Ц395.

752

www.obgyn.nct/newsrx/womens_health-Colorectal_Cancer-20001214-7.asp

753

http://info.cancerresearchuk.org/healthyliving/dietandhealthycating/theepicstudy

754

www.ucdmc.ucdavis.edu/ucdhs/health/a-z/06BreastCancer/doc06lowerisk.html

755

Epidem. 1994, 23 (6), 1133Ц1136.

756

Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ, 332, 70.

757

Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer, 5, 69Ц96.

758

http://cis.nci.nih.gov/fact/3_13.htm

759

Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ, 325, 6 July 2002, 8.

760

Writing Group for the Women's Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association, 288, є 3.

761

Collaborative Group on Hormonal Factors in Breast Cancer, 1997. Breast cancer and hormone replacement therapy. Lancet, 350, 1047Ц1059.

762

Schairer, C., Lubin, J., Troisi, R., and others, 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283(4), 485Ц491.

763

www.nih.gov/news/pr/nov2002/nichd-29.htm

764

Ross, R.K., Paganini-Hill, A., Wan, P.C. and others, 2000. Effective hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl Cancer Inst, 92, 328Ц332. Schairer, C., Lubin, J., Troisi, R. and others. 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283 (4), 485Ц491.

765

The Times. 15 December 2006.

766

Ernst, E (editor), 2001. The Desktop Guide to Complementary and Alternative Medicine: an evidence based approach. Mosby.

767

Lee, John R, 1999. Natural Progesterone. Second revised edition. Jon Carpenter.

768

Cowan, L.D., Gordis, L., Tonascia, J.A. and Jones, G.S., 1981. Breast cancer incidence in women with a history of progesterone deficiency. Am. J. Epidemiology, 114, 209Ц217.

769

Hrushesky, W.J.M., 1996. Breast cancer, timing of surgery, and the menstrual cycle: call for prospective trial. J. Women's Health, 5, 555Ц566.

770

Mohr, P.E., Wang, D.Y., Gregory, W.M., Richards, M.A. and Fentiman, I.S., 1996. Serum progesterone and prognosis in operable breast cancer. British J. Cancer, 73, 1552Ц1555.

771

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

772

Dibble, S.L. and others, 2002. Risk factors for ovarian cancer; lesbian and heterosexual women. Oncol Nursing Forum, 29 (1), El-7.

773

Ives, A. and Semmens, J., 2007. Pregnancy after breast cancer: population based study. BMJ, 334, 194.

774

www.cancer.org/docroot/cri/content/cri_2_4_5x_what_happens_after_treatment_5.asp?sitearea=cr

775

http://www.cancer.org/docroot/cri/content/cri_2_6x_can_having_an_abortion_cause_or_contribute_to_breast_cancer.asp

776

http://www.cancer.org/docroot/cri/content/cri_2_6x_can_having_an_abortion_cause_or_contribute_to_breast_cancer.asp

777

www.cspinet.org/new/200206251.html

778

Campbell, T., Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

779

Kannel W.B. and others, 1961. Factors of risk in the development of coronary heart disease Ц six year follow up experience. Anna. Internal medi., SS.

780

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

781

Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59 (Suppl.), 11 535Ц11 615.

782

Marwick, Charles, 2003. Food industry obfuscates healthy eating message, BMJ, 327, 121.

783

Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006, The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.

784

Schlosser, Eric, 2002. Fast Food Nation. Penguin Books.

785

Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, 21 July 2002, 46Ц54.

786

Mercer, Chris, 2007. EU unveils milk shake-up plans, www.foodnavigator.com

787

http://www.cafod.org.uk

788

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

789

Ќекоторые ученые также св€зывают диабет 1-го типа с потреблением коровьего молока младенцами и детьми, особенно с генетической склонностью к диабету.

790

Anon, 2003. UK supports exclusive breast feeding for six months. BMJ, 326, 1052.

791

Laurens, Claire, 2003. Baby milk company fined for advertising direct to consumers. BMJ, 327, 307.

792

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

793

Atkins, P.J., 2005. Fattening children or fattening farmers? School milk in Britain, 1921Ц1941. Economic H-58.

794

http://www.nationaldairycouncil.org

795

Kradjian, R.M., 1994. Save Yourself from Breast Cancer. Berkley Books, New York.

796

Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine. 21 July 2002, 46Ц54.

797

Outwater, J.L. and others, 1997. Dairy Products and Breast Cancer: the IGF-1, estrogen and bGH hypothesis. Mod Hypotheses. 48, 453Ц461.

798

European Commission, Scientific Committee on Veterinary Measures relating to Public Health. 1999. Report on Public Health Aspects of the Use of Bovine Somatotropin, 15Ц16 March.

799

Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer. inst., 92, 1472Ц1489.

800

http://www.milksucks.com/osteo.html

801

New, S.A. and Francis, R.M., 2003. Science in Parliament, 60 (4), 21.

802

Plant, Jane and Tidey, Gill, 2004. Science in Parliament. 61 (1), 28.

803

Kradjian, R.M., 1994. .Save Yourself from Breast Cancer. Berkley Books, New York.

804

New, S.A. and Francis, R.M., 2004. Science in Parliament, 61 (3), 21.

805

Robbins, John, 1987. A Diet for a New America. Stillpoint.

806

¬ 1962 году –ейчел  арсон написала книгу Ђћолчалива€ веснаї, в которой призвала ученых, работающих в области сельского хоз€йства, и членов правительства отказатьс€ от повсеместного отравлени€ планеты пестицидами, а общественность Ц изменить отношение к роли человека в природе.  нига основана на научных доказательствах и фактической информации о вреде пестицидов, гербицидов и других опасных химических веществ, которые примен€лись в промышленности и сельском хоз€йстве. Ц ѕримеч. ред.

807

www.foodnavigator.com

808

Parry, Vivienne, 2007. It's udder confusion. The Times (Body and Soul). 20 January 2007.

809

Butler, Justine, 2007. Second opinion. The Times (Body and Soul), 27 January 2007.

810

ICON, 2006, issue 4.

811

Bristow, A., 2002. Organic processed food. Which? April 2002, 22Ц23.

812

Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine, 21 July 2002. 46Ц54.

813

Bristow, A., 2002. Organic processed food. Which? April 2002, 22Ц23.

814

Inside Story. Which? April 2002, 4.

815

Clapp, R.W., Howe, K.H, and Jacobs, M.M., 2005. Environmental and occupational causes of cancer, www.sustainableproduction.org

816

Plant, J.A., Turner, K.T., and Highley, D.E., 1998. Minerals and the environment. Proceedings of Minerals '98 Conference, June 1998: Republished in the Mineralogical Society Bulletin, No. 119, July 1998, 3Ц11; Mineral Planning 77, December 1998, 3Ц8; IM&M Journal, December 1998, 1, 12, 331Ц336.

817

Kushi L.H. and others, 2007. Lifestyle factors and survival in women with breast cancer. The Journal of Nutrition, Special supplement; Intern. Research conf. on food, nutrition and cancer, 236S-242S.

818

Getz, Linn, Sigurdsson, Johann A. and Hetlevik, Irene, 2003. Is opportunistic disease prevention in the consultation ethically justifiable? BMJ, 327, 498.

819

Research muddled by political pressures. The Times (Public Agenda), 19 August 2003.

820

Chaturvedi, P., 2003. Medical community may be partly responsible for cancer misery. BMJ, 326, 1146.

821

Kmietowicz, Zosia, 2002. Research spending on cancers doesn't match their death rates. BMJ, 325, 920.

822

Smith, Richard, 2003. Do patients need to read research? BMJ, 326, 3307.

823

Smith, Richard, 2003. Do patients need to read research? BMJ, 326, 1307.

824

Corrie, Pippa, Shaw, Justin and Harris, Roy, 2003. Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study. BMJ, 327, 320Ц321.

825

Wald, Nicholas J. and Morris, Joan KЕ 2003. Teleoanalysis: combining data from different types of study. BMJ, 327, 616Ц618.

826

The Times (Public Agenda), 6 March 2007.

827

Smith, Richard, 2003. Editor's choice: The screening industry. BMJ, 326, 26 April 2003.

828

Lechin, Fuard and others, 2002. Neurocircuitry and Neuroautonomic Disorders. Karger.

829

Gottlieb, Scott, 2003. US drug sales continue to rise. BMJ, 326, 518.

830

Gottlieb, Scott, 2002. Drug companies maintain 'astounding' profits, BMJ, 324, 1054.

831

Kjaergard, Lise L. and Als-Nielsen, Bodily 2002. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ, 325, 249Ц252.

832

Eaton, Lynn, 2003. Readers want transparency in link between doctors and drug firms. BMJ, 326, 1352.

833

Mayor, Susan, 2002. Researchers claim clinical trials are reported with misleading statistics. BMJ, 324, 1353.

834

JAMA, 2003, 389, 454Ц465, quoted by Hopkins Tanne, Janice, 2003. Industry is deeply involved in funding US research. BMJ, 326, 179.

835

Tonks, Alison, 2002. Authors of guidelines have strong links with drugs industry. BMJ, 324, 383.

836

Spurgeon, David, 2002. Doctors accept $50 a time to listen to drug representatives. BMJ, 324, 1113.

837

Gottlieb, Scott, 2003. A fifth of Americans contact their doctor as a result of direct to consumer drug advertising. BMJ, 325, 854.

838

BMJ, 2003. Drug companies want to inform patients. BMJ, 326, 1286.

839

Watson, Rory, 2003. EU health ministers reject proposal for limited direct to consumer advertising. BMJ, 326, 1284.

840

Watson, R., 2006. Cancer group denies company funding will influence its agenda. BMJ, 333, 874.

841

Mayor, Susan, 2002. GMC issues new guidance on clinical research. BMJ, 324, 384.

842

Marwick, Charles, 2002. US tackles drug company gifts to doctors. BMJ, 325, 795.

843

Mosconi, Paola, 2003. Declaration of competing interests is rare in Italian breast cancer associations. BMJ, 327, 344.

844

Herxheimer, A., 2003. Relationships between the pharmaceutical industry and patients' organisations. BMJ, 326, 1208Ц1210.

845

Hirst, J., 2003. Charities and patient groups should declare interests. BMJ, 326, 1211.

846

Clark, Jocalyn, 2003. A hot flush for Big Pharma. BMJ, 327, 400.

847

Writing Group for the Women's Health Initiative Investigators, 2002. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women. JAMA, 288, 321Ц333.

848

The Times, 15 December 2006.

849

Moynihan, Ray, 2003. US seniors group attacks pharmaceutical industry 'fronts'. BMJ, 326, 351.

850

Cho, E, and others, 2006. Red meat intake and risk of breast cancer among premenopausal women. Archivesof International Medicine, 166, 2253Ц2259.

851

Lenzer, Jeanne, 2002. The operation was a success (but the patient died). BMJ, 325, 664.

852

Moynihan, Ray, 2003. Blurring the boundaries. BMJ. 326, 1094.

853

The selling of a wonder drug. The Guardian, 29 March 2006.

854

http://en.wikipedia.org/wiki/Trastuzumab.

855

Barrett, A. and others, 2006. How much will Herceptin really cost? BMJ, 333, 118Ц120.

856

Bartlett, Christopher, Sterne, Jonathan and Egger, Matthias, 2002. What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ, 325, 81.

857

http://www.madnessmansion.com/!!jimkc/txt/ambulanc.txt/ http://www.public.asu.edu/!!tadams2/Quotes/Ambulance

858

www.cancersupportinternational.com

859

Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.

860

Robbins, John, 1987. A Diet for a New America. Stillpoint.

861

Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.

862

–ейки Ц древн€€ энергетическа€ система, пришедша€ к нам из “ибета, а оттуда распространивша€с€ на ≈гипет, ƒревнюю √рецию, –им, »ндию и далее на восток, в  итай и японию. –ейки было доступно немногим посв€щенным и сохран€лось в строгой тайне. Ёто древнее знание со временем было почти утер€но и вновь открыто в конце прошлого столети€ доктором ћикао ”суи в японии. ÷ель рейки Ц помочь организму войти в состо€ние равновеси€-гармонии, чтобы он мог излечитьс€ сам. Ц ѕримеч. ред.

863

—м. Daniel Cramer 1989, Lancet 2, 66Ц71.

¬ернутьс€ к просмотру книги ¬ернутьс€ к просмотру книги